Content |
Chapter Title Page
Drawings
MCL_P132_EIA_5-3-001
Operational Air Quality Assessment area
MCL_P132_EIA_17-3-002
Locations of Representative Human Receptors (in Lantau West)
MCL_P132_EIA_17-3-003
Locations of Representative Human Receptors (in Lantau East)
MCL_P132_EIA_17-3-004
Locations of Representative Human Receptors (in Siu Ho Wan)
MCL_P132_EIA_17-3-005
Locations of Representative Human Receptors (in Tuen Mun)
MCL_P132_EIA_17-3-006
Locations of Representative Human Receptors (at HKIA)
Appendices
Appendix 17.2.1 Speciation Profiles of TAP from Aircraft Emission
and Other Key Emissions
Appendix 17.2.2 TAP Toxicity and Screening Results
Appendix 17.2.3 Background TAP Concentration
Appendix 17.2.5 Risk Characterisation
Appendix 17.2.7 Breakdown for Hospital Admission, Short-term
Mortality and Long-term Mortality
Appendix
17.3.1 List of Publications Identified for Initial Screening
and Bibliography
Appendix
17.3.3 HIA Exposure-Response
Appendix
17.3.4 Technical Note on Population Estimates for Aircraft Noise Health Impact
Assessment
ˇ Identification of key components of TAP from the aircraft emissions and associated activities during the operation of the project for health impact assessment;
ˇ Assessment of the likelihood and consequences of exposure to the identified key components of TAP emissions;
ˇ Identification of means by which the health impact could be further reduced;
ˇ Recommendations of reasonably practical measures, if any, to reduce the health impact during the operation of the project.
ˇ World Health Organization (WHO) publications (e.g. WHO guidelines for indoor air quality: selected pollutants, 2010; Air Quality Guidelines Global Updates, 2005; Air Pollution and Cancer. IARC Scientific Publication no. 161., 2013; Concise International Chemical Assessment Document 43 - Acrolein, 2002);
ˇ United States Environmental Protection Agency (USEPA) publications (e.g. Toxicological Review, 2012; Health Assessment Document For Diesel Engine Exhaust, 2002);
ˇ International Air Transport Association (IATA), Federal Aviation Administration (FAA) and International Civil Aviation Organization (ICAO) publications (e.g. ICAO Airport Air Quality Manual, 2011); and
ˇ Public domain websites (e.g. USEPA
IRIS: http://www.epa.gov/IRIS/;
USEPA SPECIATE Data Browser http://cfpub.epa.gov/si/speciate/ehpa_speciate_browse.cfm;
OEHHA – Hot Spots Guidelines http://oehha.ca.gov/air/hot_spots/index.html).
Table 17.2.1: Summary of desktop research on international HIA methodology guidelines
Item |
Literature |
Organisation |
Year |
Methodology |
1 |
Evaluation
and use of epidemiological evidence for environmental health risk assessment |
WHO |
2000 |
· The document specifies the key HIA steps
as follows: -
Specify the purpose and framework of the
impact assessment -
Specify the method(s) used to quantify
uncertainty -
Specify the measure(s) of exposure -
Specify the range of exposure to be
considered -
Derive the population exposure distribution -
Specify the time window between exposure
and effect -
Select appropriate health outcome(s) -
Estimate the exposure-response relationship
in the population of interest -
Derive population baseline frequency
measures for the relevant health outcomes -
Calculate the number of attributable cases |
2 |
WHO Air Quality Guidelines - Global Update
2005 |
WHO |
2005 |
· The HIA assessment due to outdoor air
pollution is based on four components as follows: -
Identify pre- and post-air-pollution
concentrations and exposure assessment; -
Determine size and composition of
population groups exposed to current levels of air pollution -
Establish concentration response (CR) functions for background incidence of mortality and morbidity - Estimate
the impact functions |
3 |
APHEIS:
Health Impact Assessment of Air Pollution and Communication Strategy |
Air Pollution and Health : A
European Information
System, EU |
2005 |
· Focus on Black Smoke and PM · The key HIA steps shall include: - Specification
of exposure - Defining the appropriate health outcomes - Specification
of the exposure-response relationship - Derivation population baseline frequency
measures for the health outcomes - Calculation
of the number of cases · Analysis of the acute
effects of PM10 and Black
Smoke on premature mortality and hospital admissions · Estimation of the impact on premature
mortality of long-term exposure to PM10 and PM2.5 |
4 |
CAFÉ Program Methodology for the Cost-Benefit analysis for
CAFE: Volume 2: Health Impact Assessment |
AEA
Technology Environment / European Commission DG Environment |
2005 |
The systematic
approach for HIA shall include: · Identification of sources and
quantification of pollutant emissions · Calculation of dispersion · Incorporation of exposure response
functions to estimate yield loss · Valuation of yield loss using world market
prices |
5 |
ACRP Report 7 - Aircraft
and Airport-Related Hazardous Air Pollutants: Research Needs and Analysis |
Airport Cooperative
Research Program Transportation Research Board |
2008 |
· Emissions of TAP were considered · Integration
of Emission Rates with Toxicology for Prioritization of Airport Hazardous Air Pollutants · Risk-based
concentrations (RBCs) for cancer and noncancerous health effects were
proposed · Acute
exposure guidelines (AEGLs), acute minimal risk levels (MRLs), and acute
inhalation reference exposure levels (RELs) were proposed |
6 |
A Method
to Estimate the Chronic Health Impact of Air Pollutants in .US. Residences |
Ernest
Orlando Lawrence Berkeley National Laboratory |
2011 |
· Disability-Adjusted Life Years (DALY) Method adopted · For criteria pollutants (ozone, NO2,
PM2.5, SO2, and CO), an Intake-Incidence-DALY (IND)
method that uses epidemiology based concentration-response functions shall be
adopted to quantify disease incidence rates. These are combined with estimates
of DALYs per disease incidence reported in the literature · For TAP, an Intake-DALY (ID) approach
which used the work of Huijbregts et al. (2005) shall be adopted to
calculate the health impact associated with intake of non-criteria pollutants
based on animal toxicity literature |
Table 17.2.2: Summary of desktop
research on HIA methodologies adopted in other airport related studies
Item |
Literature |
Organisation |
Year |
Methodology |
7 |
Health
Impact Assessment Schiphol Airport |
National
Institute of Public Health and Environmental Protection (RIVM) |
1994 |
· Both criteria pollutants and TAP were
considered · Inhalation exposure pathway was considered · Incremental risk was considered · Increase in respiratory symptoms was
considered · Increase in cancer risk was considered |
8 |
Human
health risk assessment for LAX Master Plan EIS / EIR |
Los
Angeles World Airport |
2001 |
· Only TAP were
considered. · Inhalation and ingestion pathway were
considered · Toxicity-weighted emissions were
established for TAP screening · Acute and chronic risk were calculated |
9 |
EIS for
Chicago O’Hare International Airport |
Chicago
O’Hare International Airport |
2005 |
· Only TAP were considered · Inhalation exposure pathway was considered · No quantification of TAP concentrations · Comparison of toxicity-weighted emissions
between with and without-project scenarios |
10 |
HIA - Finningley Airport |
Doncaster
Health Authority |
2000 |
· Both criteria pollutants and TAP were
considered · Inhalation exposure pathway was considered · Comparison with Air Quality Criteria and
WHO guidelines |
11 |
Health
Impact Assessment for Brisbane Airport |
Brisbane
Airport Corporation Pty Limited |
2007 |
· Both criteria pollutants and TAP were
considered · Inhalation exposure pathway was considered · Incremental risk was considered · The acute health effects examined include: - Mortality and hospital admission (for
criteria pollutants) - Lung function, symptoms and GP visits (for
criteria pollutants) · The long term effects considered include: - Mortality (for criteria pollutants) - Cancer incidence (for TAP) - Lung function growth in children (for
criteria pollutants) |
12 |
EIS for
Fort Lauderdale-Hollywood International Airport |
Landrum
& Brown, Incorporated |
2007 |
· Only TAP were considered · Comparison of TAP emission inventories
only · No quantification of TAP concentrations |
13 |
Health Impact Assessment of Second Runway for Stansted Airport -
Generation 2 Development |
Stansted
Airport |
2008 |
· Incremental risks due to PM and NO2
were considered · Inhalation exposure pathway was considered · Years of life lost were considered · Respiratory hospital admissions were
considered · Cardiovascular hospital admissions were
considered · GP consultations for asthma were
considered · Chronic Bronchitis was considered · Restricted activity days were considered · Lower respiratory symptoms were considered · Qualitatively addressed the ingestion
exposure path due to polycyclic aromatic hydrocarbons (PAHs) |
14 |
High-Priority
Compounds Associated with Aircraft Emissions |
U.S.
Federal Aviation Administration Office of Environment and Energy
(Funder) |
2008 |
· The risk-based prioritisation included three
components: - Emissions determination - Identification of the emission-to-exposure
relationship (including pollutant fate and transport and population patterns) - Determination of the toxicity of compounds · Primarily focused on total population
health risks, rather than considering the maximum individual health risks
found within the population · Optimal spatial domain and resolution for
atmospheric dispersion modelling may differ across pollutants as well as
across airports · Ranking differences across airports |
15 |
Santa
Monica Airport Health Impact Assessment (HIA) |
UCLA
Department of Paediatrics |
2010 |
· Consideration of both criteria pollutants
and TAP Adopt rapid non-participatory health impact assessment · Inhalation exposure path was considered · Conducting empirical and scientific
literature reviews |
16 |
General
Aviation Airport Air Monitoring Study |
USEPA |
2010 |
· Long-term monitoring of TAP concentrations
within and in the vicinity of the airports |
Table 17.2.3: Summary of desktop research on HIA methodologies adopted in other EIA studies and feasibility studies
Item |
Literature |
Organisation |
Year |
Methodology |
17 |
Assessment
of Toxic Air Pollutant Measurements in Hong Kong |
HKEPD |
2003 |
· Both criteria pollutants and TAP were
considered · Inhalation exposure path was considered · Non-cancer risk and cancer risk was
presented · Dietary intake for dioxin was considered |
18 |
EIA for
Sludge Treatment Facilities |
HKEPD |
2008 |
· Both criteria pollutants and TAP were
considered · Inhalation exposure path was considered · Acute and chronic non-cancer risk, and
cancer risk were presented · Risk due to criteria pollutant (except Pb) was checked against the Air Quality Objectives (AQO) |
19 |
Review of
Air Quality Objectives and Development of a Long Term Air Quality Strategy
for Hong Kong – Feasibility Study |
Arup /
HKEPD |
2009 |
· Criteria pollutants were considered · Inhalation exposure was considered · Incremental risk was considered · Increase in hospital admission, mortality,
etc were considered · Health cost was quantified |
20 |
EIA for
Development of the Integrated Waste Management Facilities Phase 1 |
HKEPD |
2011 |
· Both criteria pollutants and TAP were
considered · Inhalation, ingestion exposure (including
consumption of drinking water and fish, consumption of animal products,
consumption of aboveground produce) were considered · Incremental cancer risk was considered · Risk due to criteria pollutant (except Pb) was checked against the AQO · Project contribution concentration to
determine the acute and other non-cancer risk |
Table 17.2.4: Summary of approaches in determination of health risk identified from the literature review
Approaches
|
Item
|
Pollutants
Covered
|
Comparison of toxicity-weighted emissions
|
Items
9 and 12
|
TAP
|
Comparison
with air quality criteria
|
Item 10
|
Criteria Pollutants
|
Conducting empirical and scientific literature reviews
|
Item 15
|
TAP and Criteria Pollutants
|
Disability-Adjusted
Life Years (DALY) Method
|
Item 6
|
Criteria Pollutants
|
Evaluation of acute and chronic
non-cancer health risks as well as cancer risk
|
Items
1-5, 7, 8, 11, 13, 14, 17 – 20
|
TAP and Criteria Pollutants
|
Table 17.2.5: The limitation of different risk assessment approaches
Approaches
|
Limitation
|
Comparison
of toxicity-weighted emissions
|
Not able to determine the consequences
of exposure as specified in the EIA Study Brief
|
Comparison
with air quality criteria
|
Applicable to criteria pollutants only; not able
to determine the likelihood and consequences of exposure as specified in the
EIA Study Brief for TAP.
|
Conducting
empirical and scientific literature reviews
|
Not able to determine the likelihood and
consequences of exposure as specified in the EIA Study Brief
|
Disability-Adjusted
Life Years (DALY) Method
|
Not standardised method and results
depend very much on the assumptions used.
|
Hazard Identification
Exposure
Assessment
Dose-Response
Assessment
Risk Characterisation
Table 17.2.6: Ozone concentrations for with and without airport scenarios under northern wind direction
Area |
Ozone under the with airport case
(3RS), µg / m3 |
Ozone under the without airport
case, µg / m3 |
Difference (with airport – without
airport), µg / m3 |
Lung Kwu Chau PATH grid (8,30) |
361 |
361 |
0 |
PH1(Airport North Station) PATH grid (12,28) |
316 |
325 |
- 9 |
PH5 (Airport South Station) PATH grid (11,26) |
287 |
321 |
- 34 |
Tung Chung Air Quality Monitoring Station PATH
grid (12,25) |
277 |
302 |
- 25 |
Lantau Central PATH grid (12,23) |
269 |
272 |
-4 |
Lantau South PATH grid (12,21) |
244 |
244 |
0 |
Table 17.2.7: Ozone concentrations for with and without airport scenarios under southern wind direction
Area |
Ozone under the with airport case
(3RS), µg / m3 |
Ozone under the without-airport
case, µg / m3 |
Difference (with airport – without
airport), µg / m3 |
Lantau Central PATH grid (12,23) |
128 |
128 |
0 |
Tung Chung Air Quality Monitoring Station PATH grid (12,25) |
121 |
122 |
-1 |
PH5 (Airport South Station) PATH grid (11,26) |
106 |
111 |
-5 |
PH1(Airport North Station) PATH grid (12,28) |
75 |
79 |
-4 |
Lung Kwu Chau PATH grid (8,30) |
93 |
103 |
-10 |
Yuen Long Air Quality Monitoring Station (18,38) |
133 |
133 |
0 |
Table 17.2.8: Ozone concentrations for with and without airport scenarios under western wind direction
Area |
Ozone under the with airport case
(3RS), µg / m3 |
Ozone under the without-airport
case, µg / m3 |
Difference (with airport – without
airport), µg / m3 |
Lung Kwu Chau PATH grid (8,30) |
162 |
162 |
0 |
PH1 (Airport North Station) PATH grid (12,28) |
115 |
225 |
-110 |
Central Western Air Quality Monitoring Station PATH grid (27, 25) |
146 |
174 |
-28 |
Table 17.2.9: TAP considered in various international guidelines
TAP |
ICAO [1] |
USEPA [2] |
USEPA [3] |
FAA [4] |
ACRP [5] |
1,3-butadiene |
ü |
ü |
ü |
ü |
ü |
Acetaldehyde |
ü |
ü |
ü |
ü |
ü |
Acrolein |
ü |
ü |
ü |
ü |
ü |
Benzene |
ü |
ü |
ü |
ü |
ü |
Diesel Particulate
Matters |
ü |
|
|
|
|
Ethylbenzene |
|
ü |
ü |
|
ü |
Formaldehyde |
ü |
ü |
ü |
ü |
ü |
Isopropylbenzene (cumene) |
|
|
ü |
|
|
Lead |
ü |
ü |
|
ü |
|
m-Xylene + P-xylene
+o-Xylene |
ü |
ü |
ü |
ü |
|
Naphthalene |
ü |
|
ü |
ü |
ü |
n-Hexane |
|
ü |
|
|
|
PAH / POM |
|
ü |
|
|
|
Phenol (carbolic acid) |
|
|
ü |
|
|
Propionaldehyde |
ü |
ü |
ü |
ü |
|
Styrene |
|
ü |
|
|
|
Toluene |
ü |
ü |
ü |
ü |
|
Notes:
[1] ICAO, Air Quality Manual, 2011.
[2] USEPA, Source Identification and Base Year 1990 Emission Inventory Guidance for Mobile Sources HAPs on the OAQPS List of 40 Priority HAPs, 1997.
[3] USEPA, Recommended Best Practice for Quantifying Speciated Organic Gas Emissions from Aircraft Equipped with Turbofan, Turbojet, and Turboprop Engines, 2009.
[4] FAA, Select resource materials and annotated bibliography on the topic of hazardous air pollutants (HAPs) associated with aircraft, airports and aviation, 2003.
[5] ACRP, Aircraft and Airport-Related Hazardous Air Pollutants: Research Needs and Analysis, 2008.
Table 17.2.10: TAP considered in various airport-related health impact assessments / monitoring
TAP |
Brisbane Airport |
Finningley Airport |
Chicago O’Hare International Airport |
Fort Lauderdale-Hollywood International Airport |
Los Angeles International Airport |
Santa
Monica Airport |
Schipol Airport |
General
Aviation Airport Air Monitoring Study |
London Stansted Airport |
High-Priority Compounds Associated with Aircraft Emissions |
1,3-butadiene |
|
|
ü |
ü |
ü |
|
|
ü |
|
ü |
Acetaldehyde |
|
|
ü |
ü |
ü |
|
|
ü |
|
ü |
Acrolein |
|
|
ü |
ü |
ü |
|
|
|
|
ü |
Benzene |
ü |
ü |
ü |
ü |
ü |
|
ü |
ü |
|
ü |
Diesel Particulate Matter |
|
|
ü |
ü |
ü |
|
|
|
|
|
Formaldehyde |
ü |
|
ü |
ü |
ü |
|
|
ü |
|
ü |
Lead |
|
ü |
|
ü |
|
|
|
ü |
|
|
Naphthalene |
|
|
ü |
ü |
ü |
|
|
|
|
ü |
Propionaldehyde |
|
|
|
ü |
|
|
|
|
|
ü |
Toluene |
ü |
|
ü |
ü |
ü |
|
|
ü |
|
ü |
Xylene |
ü |
|
|
ü |
ü |
|
|
|
|
ü |
Ethylbenzene |
|
|
|
ü |
|
|
|
ü |
|
ü |
n-Hexane |
|
|
|
ü |
|
|
|
|
|
|
Styrene |
|
|
|
ü |
|
|
|
|
|
ü |
PAH / POM |
|
ü |
|
ü |
ü |
ü |
ü |
|
|
ü |
Arsenic |
|
|
ü |
ü |
ü |
|
|
|
|
|
Chromium VI |
|
|
ü |
ü |
ü |
|
|
|
|
|
Nickel |
|
|
ü |
ü |
ü |
|
|
|
|
|
2,2,4-Trimethylpentane |
|
|
|
ü |
|
|
|
|
|
|
TCDD |
|
|
|
|
ü |
|
|
|
|
|
Beryllium |
|
|
|
|
ü |
|
|
|
|
|
Cadmium |
|
|
|
|
ü |
|
|
|
|
|
Copper |
|
|
|
|
ü |
|
|
|
|
|
Manganese |
|
|
|
|
ü |
|
|
|
|
|
Zinc |
|
|
|
|
ü |
|
|
|
|
|
SO2 |
|
ü |
|
|
|
|
ü |
|
|
ü |
NO2 |
ü |
ü |
|
|
|
|
ü |
|
ü |
ü |
CO |
ü |
ü |
|
|
|
|
ü |
ü |
|
ü |
RSP / FSP / UFP |
ü |
ü |
|
|
|
ü |
|
ü |
ü |
ü |
Black Smoke |
|
|
|
|
|
ü |
ü |
|
|
|
Ozone |
|
ü |
|
|
|
|
|
|
|
ü |
Note:
[1] Table 17.2.2 shall be referred to for a summary of the approaches adopted in the various HIA studies.
ˇ Tier 1: Screening based on calculation of emission-toxicity values;
ˇ Tier 2: Reference to IARC Group 1 (Carcinogenic to human) Chemicals; and
ˇ Tier 3: Reference to TAP identified in other airport-related studies.
ˇ Identify all the inhalation unit risks (IURs) and reference concentrations (RfCs) for the TAP of interest;
ˇ Determine the emission rate (e.g. tons/year) of each TAP;
ˇ Multiply the emission rate of each TAP by its IUR where applicable to obtain an emission-toxicity value for each TAP of interest with respect to carcinogenic effect;
ˇ Similarly, divide the emission rate of each TAP by its RfC to obtain an emission-toxicity value for each TAP with respect to non-carcinogenic effect;
ˇ Rank the emission-toxicity values calculated and sum all emission-toxicity values for carcinogenic and non-carcinogenic effects respectively; and
ˇ Starting with the highest emission-toxicity values calculated,
proceed down the list until the cumulative sum of the emission-toxicity values
reaches a large proportion (i.e. 99.9%) of the total for all the TAP.
1. Worldwide level (such as WHO);
2. Country level (e.g. countries with well-established environmental regulations, such as USEPA – IRIS, USEPA – ASTDR); and
3. Local level (i.e. state / city of countries with well-established environmental regulations, such as California EPA – OEHHA).
ˇ 1,3-Butadiene ˇ Acetaldehyde ˇ Acrolein ˇ Arsenic ˇ Benzene ˇ Cadmium ˇ Chromium VI ˇ Copper |
ˇ Diesel Particulate Matter ˇ Formaldehyde ˇ Lead ˇ Manganese ˇ Naphthalene ˇ Nickel ˇ Propionaldehyde ˇ Xylene |
ˇ Benzo(a)pyrene
ˇ Beryllium
ˇ TCDD
ˇ 2,2,4-Trimethylpentane ˇ Benzo(a)anthracene ˇ Benzo(bk)fluoranthene ˇ Chrysene ˇ Dibenz(a,h)anthracene ˇ Ethylbenzene ˇ Indeno(1,2,3-cd)pyrene |
ˇ Isopropylbenzene (cumene) ˇ Phenol (carbolic acid) ˇ Methanol ˇ n-Hexane ˇ Styrene ˇ Toluene |
Table 17.2.11: Summary of short-listed TAP
Type
|
TAP
|
VOC
|
1,3-Butadiene, Acetaldehyde, Acrolein, Benzene, Formaldehyde, Propionaldehyde, Xylene, Isopropylbenzene (cumene), Methanol, Phenol (carbolic acid), n-Hexane, Ethylbenzene, Styrene, Toluene
|
PM
|
Diesel
Particulate Matter
|
Heavy Metals
|
Arsenic, Beryllium, Cadmium, Chromium VI, Copper, Manganese, Nickel, Lead
|
PAH/Dioxin
|
Naphthalene, Benzo(a)pyrene, Benzo(a)anthracene, Benzo(bk)fluoranthene, Chrysene, Dibenz(a,h)anthracene, Indeno(1,2,3-cd)pyrene, TCDD
equivalent
|
Note: Lead is evaluated as both a TAP and a criteria pollutant.
Determination of Modelling Scenarios
Table 17.2.12: Modelling scenarios to be assessed
Scenario |
Description |
Assessment Year |
1 |
Highest aircraft emission scenario |
Year 2031 According to the EIA Study Brief, the
selected year of assessment represents the highest aircraft emission
scenario, taking into consideration the number of landing take-off cycles and
the corresponding aircraft engine emission factors for the selected year. Moreover, the highest incremental
changes (3RS – 2RS) of aircraft emissions of RSP, NO2, SO2,
CO and VOC are predicted to occur in Yr 2031. |
2 |
Without project scenario |
Same year as Scenario 1, but based on a two- runway system under the business as usual case. The purpose of this scenario is to establish the
baseline scenario of the additional health impact due to
the increase, if any, of the air pollutants arising from the project. |
Human Receptors Identification
Table 17.2.13: Human receptor locations considered in local and international HIA studies
HIA Studies |
Country / Cities |
Year |
Identification of Human Receptor
Locations |
The Stansted Generation
2 project – Health Impact Assessment |
UK |
2008 |
The area within the
airport boundary was excluded from the calculation of health
effects |
EIS – Los Angeles
International Airport |
US |
2009 |
Off-site sensitive receptors (i.e. residential
and schools) were identified and evaluated against the acute and chronic non
- carcinogenic risk, and carcinogenic risk. Workers inside
airport were identified and evaluated against the occupational standards
(OSHA). |
EIS – New Parallel
Runway for Brisbane Airport |
Australia |
2007 |
No sensitive
receptor was selected inside airport boundary |
EIA – Sludge
Treatment Facilities (EIA 155/2008) |
HK |
2008 |
No on-site
sensitive receptor was selected |
EIA – IWMF (EIA
201/2011) |
HK |
2011 |
No on-site
sensitive receptor was selected |
Table 17.2.14: Representative existing and planned human receptors
HSR ID |
Location |
Landuse [1] |
Acute Risk |
Chronic Risk |
|
Airport Island (Drawing No. MCL/P132/EIA/17-3-006) |
|||||
AI-C1 |
Regal Airport Hotel |
C |
Ö |
- |
|
AI-C2 |
AsiaWorld-Expo |
C |
Ö |
- |
|
AI-C3 |
AsiaWorld-Expo |
C |
Ö |
- |
|
AI-C4 |
Hong Kong SkyCity Marriot Hotel |
C |
Ö |
- |
|
AI-C5 |
Planned Northern
Commercial District |
C |
Ö |
- |
|
AI-C6 |
Planned Northern
Commercial District |
C |
Ö |
- |
|
Hong Kong Boundary Crossing Facilities (HKBCF)(Drawing
No MCL/P132/EIA/17-3-006) |
|||||
BCF-1 |
Planned Passenger Building |
GIC |
Ö |
- |
|
Tung Chung (Drawing No MCL/P132/EIA/17-3-003) |
|
|
|||
TC-1 |
Caribbean Coast Block 1 |
R |
Ö |
Ö |
|
TC-2 |
Caribbean Coast Block 6 |
R |
Ö |
Ö |
|
TC-3 |
Caribbean Coast Block 11 |
R |
Ö |
Ö |
|
TC-4 |
Caribbean Coast Block 16 |
R |
Ö |
Ö |
|
TC-5 |
Ho Yu College |
E |
Ö |
Ö |
|
TC-6 |
Ho Yu Primary School |
E |
Ö |
Ö |
|
TC-7 |
Coastal Skyline Block 1 |
R |
Ö |
Ö |
|
TC-8 |
Coastal Skyline Block 5 |
R |
Ö |
Ö |
|
TC-9 |
La Rossa Block B |
R |
Ö |
Ö |
|
TC-10 |
Le Bleu Deux
Block 1 |
R |
Ö |
Ö |
|
TC-11 |
Le Bleu Deux
Block 3 |
R |
Ö |
Ö |
|
TC-12 |
Le Bleu Deux Block
7 |
R |
Ö |
Ö |
|
TC-13 |
Seaview Crescent Block 1 |
R |
Ö |
Ö |
|
TC-14 |
Seaview Crescent Block 3 |
R |
Ö |
Ö |
|
TC-15 |
Seaview Crescent Block 5 |
R |
Ö |
Ö |
|
TC-16 |
Ling Liang Church E Wun
Secondary School |
E |
Ö |
Ö |
|
TC-17 |
Ling Liang Church Sau
Tak Primary School |
E |
Ö |
Ö |
|
TC-18 |
Tung Chung Public Library |
GIC |
Ö |
- |
|
TC-19 |
Tung Chung North Park |
P |
Ö |
- |
|
TC-20 |
Novotel Citygate
Hong Kong |
C |
Ö |
- |
|
TC-21 |
One Citygate |
C |
Ö |
- |
|
TC-22 |
One Citygate
Bridge |
C |
Ö |
- |
|
TC-23 |
Fu Tung Shopping Centre |
C |
Ö |
- |
|
TC-24 |
Tung Chung Health Centre and Air Quality
Monitoring Station |
GIC |
Ö |
- |
|
TC-25 |
Ching Chung Hau
Po Woon Primary School |
E |
Ö |
Ö |
|
TC-26 |
Po On Commercial Association Wan Ho Kan Primary School |
E |
Ö |
Ö |
|
TC-27 |
Po Leung Kuk Mrs.
Ma Kam Min Cheung Fook Sien
College |
E |
Ö |
Ö |
|
TC-28 |
Wong Cho Bau
Secondary School |
E |
Ö |
Ö |
|
TC-29 |
Yu Tung Court - Hei
Tung House |
R |
Ö |
Ö |
|
TC-30 |
Yu Tung Court - Hor
Tung House |
R |
Ö |
Ö |
|
TC-31 |
Fu Tung Estate - Tung Ma House |
R |
Ö |
Ö |
|
TC-32 |
Fu Tung Estate - Tung Shing
House |
R |
Ö |
Ö |
|
TC-33 |
Tung Chung Crescent Block 1 |
R |
Ö |
Ö |
|
TC-34 |
Tung Chung Crescent Block 3 |
R |
Ö |
Ö |
|
TC-35 |
Tung Chung Crescent Block 5 |
R |
Ö |
Ö |
|
TC-36 |
Tung Chung Crescent Block 7 |
R |
Ö |
Ö |
|
TC-37 |
Tung Chung Crescent Block 9 |
R |
Ö |
Ö |
|
TC-38 |
Yat Tung Estate - Shun Yat House |
R |
Ö |
Ö |
|
TC-39 |
Yat Tung Estate - Mei Yat House |
R |
Ö |
Ö |
|
TC-40 |
Yat Tung Estate - Hong Yat House |
R |
Ö |
Ö |
|
TC-41 |
Yat Tung Estate - Ping Yat House |
R |
Ö |
Ö |
|
TC-42 |
Yat Tung Estate - Fuk Yat House |
R |
Ö |
Ö |
|
TC-43 |
Yat Tung Estate - Ying Yat House |
R |
Ö |
Ö |
|
TC-44 |
Yat Tung Estate - Sui Yat House |
R |
Ö |
Ö |
|
TC-45 |
Village house at Ma Wan Chung |
R |
Ö |
Ö |
|
TC-46 |
Ma Wan New Village |
R |
Ö |
Ö |
|
TC-47 |
Tung Chung Our Lady Kindergarden |
E |
Ö |
Ö |
|
TC-48 |
Sheung Ling Pei |
R |
Ö |
Ö |
|
TC-49 |
Tung Chung Public School |
E |
Ö |
Ö |
|
TC-50 |
Ha Ling Pei |
R |
Ö |
Ö |
|
TC-51 |
Lung Tseung
Tau |
R |
Ö |
Ö |
|
TC-52 |
YMCA of Hong Kong
Christian College |
E |
Ö |
Ö |
|
TC-53 |
Hau Wong Temple |
W |
Ö |
Ö |
|
TC-54 |
Sha Tsui Tau |
R |
Ö |
Ö |
|
TC-55 |
Ngan Au |
R |
Ö |
Ö |
|
TC-56 |
Shek Lau Po |
R |
Ö |
Ö |
|
TC-57 |
Mo Ka |
R |
Ö |
Ö |
|
TC-58 |
Shek Mun Kap |
R |
Ö |
Ö |
|
TC-59 |
Shek Mun Kap Lo Hon Monastery |
W |
Ö |
Ö |
|
TC-P1 |
Planned North Lantau Hospital |
H |
Ö |
Ö |
|
TC-P2 |
Planned Park near One Citygate |
P |
Ö |
- |
|
TC-P5 |
Tung Chung West Development |
N/A |
Ö |
Ö |
|
TC-P6 |
Tung Chung West Development |
N/A |
Ö |
Ö |
|
TC-P7 |
Tung Chung West Development |
N/A |
Ö |
Ö |
|
TC-P8 |
Tung Chung East Development |
N/A |
Ö |
Ö |
|
TC-P9 |
Tung Chung East Development |
N/A |
Ö |
Ö |
|
TC-P10 |
Tung Chung East Development |
N/A |
Ö |
Ö |
|
TC-P11 |
Tung Chung East Development |
N/A |
Ö |
Ö |
|
TC-P12 |
Tung Chung Area
53a - Planned Hotel |
C |
Ö |
- |
|
TC-P13 |
Tung Chung Area
54 - Planned Residential Development |
R |
Ö |
Ö |
|
TC-P14 |
Tung Chung Area
55a - Planned Residential Development |
R |
Ö |
Ö |
|
TC-P15 |
Tung Chung Area
89 - Planned Primary / Secondary School |
E |
Ö |
Ö |
|
TC-P16 |
Tung Chung Area
90 - Planned Special School |
E |
Ö |
Ö |
|
TC-P17 |
Tung Chung Area
39 |
N/A |
Ö |
Ö |
|
San Tau (Drawing No MCL/P132/EIA/17-3-002) |
|
|
|
||
ST-1 |
Village house at Tin Sum |
R |
Ö |
Ö |
|
ST-2 |
Village house at Kau Liu |
R |
Ö |
Ö |
|
ST-3 |
Village house at San Tau |
R |
Ö |
Ö |
|
Sha Lo Wan (Drawing No MCL/P132/EIA/17-3-002) |
|
|
|||
SLW-1 |
Sha Lo Wan House No.1 |
R |
Ö |
Ö |
|
SLW-2 |
Sha Lo Wan House No.5 |
R |
Ö |
Ö |
|
SLW-3 |
Sha
Lo Wan House No.9 |
R |
Ö |
Ö |
|
SLW-4 |
Tin Hau Temple at Sha Lo Wan |
W |
Ö |
Ö |
|
San Shek Wan (Drawing No MCL/P132/EIA/17-3-002) |
|
|
|||
SSW-1 |
San Shek Wan |
R |
Ö |
Ö |
|
Sham Wat (Drawing No MCL/P132/EIA/17-3-002) |
|
|
|
||
SW-1 |
Sham Wat House
No. 39 |
R |
Ö |
Ö |
|
SW-2 |
Sham Wat House
No. 30 |
R |
Ö |
Ö |
|
Siu Ho Wan (Drawing No MCL/P132/EIA/17-3-004) |
|
|
|||
SHW-1 |
Village house at Pak Mong |
R |
Ö |
Ö |
|
SHW-2 |
Village house at Ngau Kwu
Long |
R |
Ö |
Ö |
|
SHW-3 |
Village house at
Tai Ho San Tsuen |
R |
Ö |
Ö |
|
SHW-4 |
Siu
Ho Wan MTRC Depot |
I |
Ö |
- |
|
SHW-5 |
Tin
Liu Village |
R |
Ö |
Ö |
|
Proposed Lantau Logistic Park (Drawing
No MCL/P132/EIA/17-3-004) |
|
||||
LLP-P1 |
Proposed Lantau Logistics Park - 1 |
N/A |
Ö |
- |
|
LLP-P2 |
Proposed Lantau Logistics Park - 2 |
N/A |
Ö |
- |
|
LLP-P3 |
Proposed Lantau Logistics Park - 3 |
N/A |
Ö |
- |
|
LLP-P4 |
Proposed Lantau Logistics Park - 4 |
N/A |
Ö |
- |
|
Tuen Mun
(Drawing
No MCL/P132/EIA/17-3-005) |
|
|
|
||
TM-7 |
Tuen Mun Fireboat
Station |
GIC |
Ö |
- |
|
TM-8 |
DSD Pillar Point Preliminary Treatment Works |
GIC |
Ö |
- |
|
TM-9 |
EMSD Tuen Mun
Vehicle Service Station |
GIC |
Ö |
- |
|
TM-10 |
Pillar Point
Fire Station |
GIC |
Ö |
- |
|
TM-11 |
Butterfly Beach
Laundry |
I |
Ö |
- |
|
TM-12 |
River Trade Terminal |
I |
Ö |
- |
|
TM-13 |
Planned GIC use opposite to TM Fill Bank |
GIC |
Ö |
- |
|
TM-14 |
EcoPark Administration Building |
C |
Ö |
- |
|
TM-15 |
Castle Peak Power
Plant Administration Building |
C |
Ö |
- |
|
TM-16 |
Customs and
Excise Department Harbour River Trade Division |
I |
Ö |
- |
|
TM-17 |
Saw Mil Number
61-69 |
I |
Ö |
- |
|
TM-18 |
Saw Mil Number
35-49 |
I |
Ö |
- |
|
TM-19 |
Ho Yeung Street Number
22 |
I |
Ö |
- |
|
Notes:
[1] R– residential; C – Commercial; E – educational; I – Industrial; H – clinic/ home for the aged/hospital; W – worship; GIC – government, institution and community; P – Recreational/Park; OS – Open Space; N/A – Not Available.
[2] The exposure time of students in school is around 8 hours per day and 5 days per week. It is similar to the working times of the working population. In addition, most students are likely to come from adjacent residential areas at which the potential health risk has already been evaluated as part of the HIA by selection of representative HSR. Therefore, they may not need to be considered in the chronic health risk. Nevertheless, as a conservative approach, schools have also been included for evaluation of potential chronic health risk.
[3] Except for Lantau Logistics Park, for those land use with “N/A”, both acute and chronic health risk were considered from a conservative point of view.
Identification of Exposure Pathways and Assessment of the Likelihood
of Exposure to the Identified TAP
ˇ Environmental health criteria for human exposure assessment, WHO (2000);
ˇ Principles for evaluating health risks in children associated with exposure to chemicals, WHO (2006);
ˇ Guidelines for exposure assessment, USEPA (1992);
ˇ Human health risk assessment protocol for hazardous waste combustion facilities, USEPA (2005); and
ˇ USEPA’s Air Toxics Risk Assessment Reference Library - Volume 2
Facility-Specific Assessment (EPA-453-K-04-001B) (2004).
Table 17.2.15: Potential exposure pathways for different population
Potential Affected Population |
Risk |
Exposure Pathways |
Residents in Tung Chung, Sha Lo Wan, San Tau, Siu Ho Wan, etc Transient Population (e.g. visitors in hotel) |
·
Acute |
Inhalation · Inhalation
of vapours and particulates |
Residents in Tung Chung, Sha Lo Wan, San Tau, Siu Ho Wan, etc |
·
Chronic |
Ingestion ·
Ingestion of potable water ·
Incidental ingestion of soil ·
Ingestion of home-grown product ·
Ingestion of contaminated food Inhalation · Inhalation
of vapours and particulates |
ˇ Oral reference dose and cancer slope factors of metallic contaminants under the “Integrated Risk Information System” developed by U.S. Environmental Protection Agency (EPA);
ˇ Agriculture, Fisheries and Conservation Department (AFCD) website (Reference to http://www.afcd.gov.hk/english/fisheries/fish_aqu/ fish_aqu.html);
ˇ Food Adulteration (Metal Contamination) Regulations (Chapter 132V); and
Food Safety Report under the Food
Surveillance Programme conducted by Centre of Food Safety (CFS) (Reference to http://www.cfs.gov.hk/english/programme/programme_fs/programme_fs.html).
Ingestion of potable water
Incidental
ingestion of soil
Ingestion
of home-grown product
Ingestion of contaminated seafood
Inhalation
Exposure
TAP Speciation Profile
Airport
Related activities TAP Emissions
Table 17.2.16: Methodology for determination of TAP speciation profile for airport activities
Emission Sources |
TAP |
Speciation Method |
Aircraft and business jet |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation profile |
DPM |
N/A |
|
Heavy metal |
· USEPA SPECIATE 4.3 database |
|
PAH |
· Naphthalene: EDMS V5.1.4.1 built-in TAP speciation profile · Other PAH: Select Resource Materials and Annotated Bibliography on the Topic of Hazardous Air Pollutants (HAPs) Associated with Aircraft, Airports, and Aviation (FAA, 2003) |
|
TCDD |
N/A |
|
APU |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation profile |
DPM |
N/A |
|
Heavy metal |
· USEPA SPECIATE 4.3 database |
|
PAH |
· Naphthalene: EDMS V5.1.4.1 built-in TAP
speciation profile · Other PAH: Select Resource Materials and Annotated
Bibliography on the Topic of Hazardous Air Pollutants (HAPs) Associated with
Aircraft, Airports, and Aviation (FAA, 2003) |
|
TCDD |
N/A |
|
GSE |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation
profile |
DPM |
· All PM from diesel engine are assumed as
DPM. |
|
Heavy metal |
· USEPA SPECIATE 4.3 database |
|
PAH |
· MOVES2010b - Additional Toxics Added to
MOVES, USEPA, 2012 |
|
TCDD |
· MOVES2010b - Additional Toxics Added to MOVES, USEPA, 2012 |
|
Helicopter |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation profile |
DPM |
N/A |
|
Heavy metal |
· USEPA SPECIATE 4.3 database |
|
PAH |
· Naphthalene: EDMS V5.1.4.1 built-in TAP
speciation profile · Other PAH: Select Resource Materials and Annotated
Bibliography on the Topic of Hazardous Air Pollutants (HAPs) Associated with
Aircraft, Airports, and Aviation (FAA, 2003) |
|
TCDD |
N/A |
|
Aviation Fuel Farm |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation profile |
DPM |
N/A |
|
Heavy metal |
N/A |
|
PAH |
N/A |
|
TCDD |
N/A |
|
Fire Training Activities |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation profile |
DPM |
N/A |
|
Heavy metal |
N/A |
|
PAH |
N/A |
|
TCDD |
N/A |
|
Engine Maintenance Center |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation profile |
DPM |
N/A |
|
Heavy metal |
N/A |
|
PAH |
N/A |
|
TCDD |
N/A |
|
Engine Testing Facilities |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation profile |
DPM |
N/A |
|
Heavy metal |
· USEPA SPECIATE 4.3 database |
|
PAH |
· Naphthalene: EDMS V5.1.4.1 built-in TAP
speciation profile · Other PAH: Select Resource Materials and
Annotated Bibliography on the Topic of Hazardous Air Pollutants (HAPs) Associated
with Aircraft, Airports, and Aviation (FAA, 2003) |
|
TCDD |
N/A |
|
Catering |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation
profile |
DPM |
· All PM from diesel engine are assumed as
DPM. |
|
Heavy metal |
· U.S. EPA AP-42 |
|
PAH |
· U.S. EPA AP-42 |
|
TCDD |
· U.S. EPA AP-42 |
|
Airport Ferries |
VOC(speciated) |
· USEPA, 2009. Documentation for Commercial
Marine Vessel of the National Emission Inventory Methodology |
DPM |
· All PM from diesel engine are assumed as
DPM. |
|
Heavy metal |
· USEPA SPECIATE 4.3 database |
|
PAH |
· Methodology for calculating emissions from
ships: 1. Update of emission factors, Swedish Environmental Protection
Agency, 2004 |
|
TCDD |
· Methodology for calculating emissions from ships:
1. Update of emission factors, Swedish Environmental Protection Agency, 2004 |
|
Car Parks |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation
profile |
DPM |
· All PM from diesel engine were assumed as
DPM. |
|
Heavy metal |
· USEPA SPECIATE 4.3 database |
|
PAH |
· MOVES2010b - Additional Toxics Added to
MOVES, USEPA, 2012 |
|
TCDD |
· MOVES2010b - Additional Toxics Added to
MOVES, USEPA, 2012 |
|
Motor Vehicles |
VOC(speciated) |
· EDMS V5.1.4.1 built-in TAP speciation
profile |
DPM |
· All PM from diesel engine were assumed as
DPM. |
|
Heavy metal |
· USEPA SPECIATE 4.3 database |
|
PAH |
· MOVES2010b - Additional Toxics Added to
MOVES, USEPA, 2012 |
|
TCDD |
· MOVES2010b - Additional Toxics Added to
MOVES, USEPA, 2012 |
Note: N/A means not applicable.
Proximity
Infrastructure TAP Emission
Table 17.2.17: Methodology for determination of TAP speciation profile for proximity infrastructure emission in Lantau area
Project / Sources |
Emission Type |
TAP Speciation |
Hong Kong Boundary Crossing Facilities (HKBCF) |
Vehicular emissions |
· VOC
(speciated) :
EDMS V5.1.4.1 built-in TAP
speciation profile |
Hong Kong Link Road (HKLR) |
Vehicular emissions |
· DPM:
All PM from diesel engine were assumed as DPM. |
Tuen Mun – Chek Lap Kok Link (TM-CLKL) (Lantau
section) |
Vehicular emissions |
· Heavy
Metals: USEPA SPECIATE 4.3 database |
North Lantau Highway (NLH) and other roads
in Tung Chung |
Vehicular emissions |
· PAH:
MOVES2010b - Additional Toxics Added to MOVES, USEPA, 2012 |
Tung Chung New Town Extension Study |
Vehicular emissions |
· Dioxin: MOVES2010b - Additional Toxics Added to
MOVES, USEPA, 2012 |
Organic Wastes
Treatment Facilities (OWTF) Phase 1 |
Chimney emissions |
· VOC (speciated): USEPA SPECIATE 4.3 database · No
DPM, heavy metals, PAH, and dioxin were identified in the approved EIA of
“Organic Waste Treatment Facilities, Phase I” |
Table 17.2.18: Methodology for determination of TAP speciation profile for proximity infrastructure emission in Tuen Mun area
Project / Sources |
Emission Type |
TAP Speciation |
Tuen Mun Western Bypass (TMWB) |
Vehicular emissions |
·
VOC (speciated): EDMS V5.1.4.1 built-in
TAP speciation profile · DPM: All PM from diesel engine were assumed as DPM. · Heavy Metals: USEPA SPECIATE 4.3 database · PAH: MOVES2010b - Additional Toxics Added to MOVES, USEPA, 2012 · Dioxin:
MOVES2010b - Additional Toxics Added to MOVES, USEPA, 2012 |
TM-CLKL (Tuen Mun
section) |
Vehicular emissions |
|
Other roads in Tuen Mun |
Vehicular emissions |
|
Shiu Wing Steel Mill |
Chimney emissions |
·
VOC (speciated): USEPA AP-42 · Heavy metal: USEPA AP-42 · PAH: USEPA AP-42 · Dioxin:
USEPA AP-42 |
Green Island Cement |
Chimney emissions |
·
VOC (speciated):
USEPA AP-42 · Heavy metals: USEPA AP-42 · PAH: USEPA AP-42 · Dioxin:
USEPA AP-42 |
Castle Peak Power Plant (CPPP) |
Chimney emissions |
· Given
that the plume from the chimney will be dispersed at a height higher than
200m and has less influence on the administrative building inside the CLPP
site, the effect of chimney is thus not taking into account for Tap Shek Kok Receivers. |
EcoPark in Tuen Mun Area 38 |
Chimney emissions |
·
VOC (speciated):
USEPA AP-42 · Heavy metals: USEPA AP-42 · PAH: USEPA AP-42 · Dioxin:
USEPA AP-42 |
Butterfly Beach Laundry |
Chimney emissions |
·
VOC (speciated):
USEPA AP-42 · Heavy metals: USEPA AP-42 · PAH: USEPA AP-42 · Dioxin:
USEPA AP-42 |
Flare at Pillar Point Valley Landfill
(PPVL) |
Chimney emissions |
· VOC (speciated): EDMS V5.1.4.1 built-in TAP speciation profile · Follow
approved EIA of “Organic Waste Treatment Facilities, Phase I” - No DPM, heavy metals, PAH, and dioxin
were identified |
Permanent Aviation Fuel Facility (PAFF) |
Emissions from fuel tanks |
· VOC (speciated) from fuel tank : EDMS V5.1.4.1 built-in TAP speciation profile ·
VOC (speciated) from chimney: USEPA
AP-42 · Heavy metals from chimney : USEPA AP-42 · PAH from Chimney: USEPA AP-42 · Dioxin
from chimney: USEPA AP-42 |
Marine |
Exhaust Emissions |
·
VOC (speciated): USEPA, 2009.
Documentation for Commercial Marine Vessel of the National Emission Inventory
Methodology ·
DPM: All PM from diesel engine were assumed as DPM. · Heavy Metals: USEPA SPECIATE 4.3 database · PAH: Methodology for calculating emissions from ships: 1. Update of emission factors, Swedish Environmental Protection Agency, 2004 · Dioxin: Methodology for calculating emissions from ships: 1. Update of emission factors, Swedish Environmental Protection Agency, 2004 |
Background
Contributions
Air
Quality Modelling for TAP
Table 17.2.19: Modelling Methodology for different type of receivers
Area |
Airport
related sources |
Proximity
infrastructure sources in Lantau |
Proximity
infrastructure sources in Tuen Mun |
Ambient
Concentrations of TAP |
North
Lantau |
AERMOD
/ CALINE |
AERMOD
/ CALINE |
- |
EPD
Tung Chung AQMS and Central Western AQMS |
Tuen
Mun |
AERMOD
/ CALINE |
- |
AERMOD
/ CALINE |
EPD
Tung Chung AQMS and Central Western AQMS |
Impact
from Airport Related Sources
Impact
from Proximity Infrastructure Sources
Impact
from Ambient Sources of Air pollutants
Table 17.2.20: Summary of emission targets in PRDEZ
Year |
Pollutants (Thousand Tonnes) |
References |
|||
SO2 |
NOx |
PM10 |
VOC |
||
2010 |
507 |
889 |
637 |
903 |
The Hong
Kong-Guangdong Joint Working Group on Sustainable Development and
Environmental Protection (JWGSDEP) 12th meeting, 2012 |
2015 |
426 |
729 |
573 |
813 |
|
2020 |
406 |
711 |
541 |
768 |
Table 17.2.21: Summary of emission targets in HKSAR
Year |
Pollutants (Thousand Tonnes) |
References |
|||
SO2 |
NOx |
PM10 |
VOC |
||
2010 |
35.5 |
108.6 |
0.63 |
33.7 |
The
Hong Kong-Guangdong Joint Working Group on Sustainable Development and Environmental
Protection (JWGSDEP) 12th meeting, 2012 |
2015 |
26.6 |
97.7 |
0.57 |
32 |
|
2020 |
23.1 |
86.9 |
0.54 |
28.6 |
Cumulative
Impact
Consequence of Exposure
Table 17.2.22: Consequences of exposure to the key TAP for airport related sources
Pollutant |
Characteristics |
Consequence |
1,3-butadiene |
1,3-butadiene is a colorless gas. At room temperature, the gas
has a gasoline-like odour. This pollutant is a
byproduct of petroleum processing and is used in the production of synthetic
rubber and plastics. It is also found in automobile exhaust, gasoline vapor,
fossil fuel incineration products, and cigarette smoke. |
The majority
of 1,3-butadiene is released into the air and humans
are typically exposed to the pollutant via inhalation. Breathing very high
levels of 1,3-butadiene for a short time may cause
central nervous system damage, blurred vision, nausea, fatigue, headache,
decreased blood pressure and pulse rate, and unconsciousness. Breathing lower
levels of this pollutant may cause irritation of the eyes, nose, and throat.
The IARC has classified 1,3-butadiene as a “group 1
known carcinogen". |
Acetaldehyde |
Acetaldehyde is a colorless, volatile liquid with
a characteristic pungent, fruity odour. Acetaldehyde is used primarily as a
chemical intermediate in the production of acetic acid, as well as a
synthetic flavouring agent. Acetaldehyde is
released to the environment in vehicle exhaust and as a product of open
burning of gas, fuel oil, and coal. |
Acute exposure to acetaldehyde can cause eye,
nose, and throat irritation and subsequent inflammation of the eyes and coughing.
This pollutant can also cause central nervous system depression, delayed
pulmonary edema, and moderate unconsciousness. Chronic inhalation exposure at
high concentrations causes adverse respiratory tract effects in animals.
Carcinogenicity studies in rats have shown that acetaldehyde causes
respiratory tract tumors. The IARC has classified acetaldehyde as a “group 2B
possibly carcinogenic to humans". |
Acrolein |
Acrolein is a clear
or yellow liquid with a disagreeable odour. Acrolein is used as an intermediate in the production of
acrylic acid, as well as a pesticide to control algae, weeds, bacteria, and
mollusks. Small amounts of acrolein can be formed
and emitted into the air when trees, tobacco, other plants, gasoline, and oil
are burned. Acrolein may also be released in to the
environment in emissions and effluents from its manufacturing and use
facilities and in emissions from combustion processes. |
Exposure to high concentrations of acrolein may damage the lungs and could cause death.
Breathing lower amounts may cause eye watering and burning of the nose and
throat and a decreased breathing rate. The USEPA has classified acrolein as “not classifiable” as to human
carcinogenicity. |
Arsenic |
Arsenic is a naturally occurring element. It is
released into the air by volcanoes, the weathering of arsenic-containing
minerals and ores, and by commercial or industrial processes. |
Acute high-level inhalation exposure to arsenic
dust or fumes has resulted in gastrointestinal effects (nausea, diarrhea,
abdominal pain); central and peripheral nervous system disorders. Chronic
inhalation exposure to inorganic arsenic of humans leads to lung cancer,
irritation of the skin and mucous membranes and effects in the brain and
nervous system. IARC classifies inorganic arsenic as "group 1 human
carcinogen". |
Benz(a) anthracene |
Benz(a) anthracene is present as a major component of the total
content of polynuclear aromatic hydrocarbons in the
environment. Human exposure to benz(a)anthracene occurs primarily
through smoking of tobacco, inhalation of exhaust emissions from gasoline
engines and incomplete combustion of fossil fuels. |
No acute health effect of Benz (a) anthracene is known this time. There is evidence that it
causes cancer in humans and it has been shown to cause liver and lung cancer
in animals. IARC classifies it as "group 2B probable human
carcinogen". |
Benzene |
Benzene is a volatile, colorless, flammable
liquid that has a sweet odour. It is a chemical
intermediate in the synthesis of compounds such as plastics, resins, nylon,
synthetic fibers, synthetic rubbers, lubricants, dyes, detergents, drugs, and
pesticides. Major sources of atmospheric releases include vehicle exhaust
emissions, evaporative gasoline fumes, emissions from vehicle service
stations, and industrial emissions. Other sources of atmospheric benzene
include cigarette smoke and landfill emissions. |
Acute inhalation exposure to benzene can result
in death, while high levels can cause drowsiness, dizziness, rapid heart
rate, headaches, tremors, confusion, and unconsciousness. Eating or drinking
foods containing high levels of benzene can cause vomiting, irritation of the
stomach, dizziness, sleepiness, convulsions, rapid heart rate, and death.
Chronic exposure to benzene causes leukemia and aplastic anemia. The IARC has
classified benzene as
a “group 1 known carcinogen". |
Benzo(a)pyrene |
Benzo(a)pyrene is present as a major component of the total
content of polynuclear aromatic hydrocarbons in the
environment. Major sources of PAHs in ambient air (both outdoors and indoors)
include residential and commercial heating with wood, coal or other biomasses
(oil and gas heating produce much lower quantities of PAH), other indoor
sources such as cooking and tobacco smoke, and outdoor sources like
motor-vehicle exhaust (especially from diesel engines), industrial emissions
and forest fires. |
In humans, BaP has been
associated with chromosomal replication errors and altered DNA in gametes
(sperm and eggs). In adults, BaP exposure was
associated with altered sperm morphology and decreased sperm numbers, and
decreased egg numbers. At high levels of acute exposure in adults, BaP has been reported to be associated with red blood
cell damage, which can lead to anemia. The IARC has classified benzo(a)pyrene as a “group 1 known carcinogen" |
Benzo(bk)fluoranthene |
Benzo(bk)fluoranthene is PAH. Sources of Benzo(bk)fluoranthene in ambient air
(both outdoors and indoors) include forest fires, industrial emissions, residential
and commercial heating with wood, coal, or other biomass fuels (oil and gas
heating produce much lower quantities of PAHs), motor vehicle exhaust (especially
diesel), and other indoor sources such as cooking and tobacco smoke. |
Carcinogenicity studies in animals show that
health concerns of Benzo(bk)fluoranthene
are associated with tumors in in the nasal cavity, larynx, trachea, pharynx,
lung and oesophagus. Benzo(bk)fluoranthene is classified as "group 2B probable
human carcinogen' based on sufficient data from animal bioassays by IARC. |
Beryllium |
Beryllium (Be) is a dark gray metal of the
alkaline earth family and is moderately rare in its natural form. Beryllium
is used industrially to harden copper, for the manufacture of nonsparking alloys for tools, in the manufacture of
lightweight alloys and ceramics, and in the construction of nuclear reactors.
However, most beryllium in the environment is released through coal burning
operations. |
Data on human toxicity from beryllium are only available
following inhalation exposures. The lung is the major target organ following
inhalation of beryllium in a variety of forms. High levels of beryllium in
air can cause an acute pneumonitis (acute beryllium disease) characterized by
edema and inflammation. Extreme cases can be fatal. Chronic exposure to low
levels of beryllium in air may lead to chronic beryllium disease (berylliosis). The IARC has classified beryllium as a
“group 1 known carcinogen". |
Cadmium |
Cadmium is an element of the transitional metal
series that occurs widely in nature, usually in sulfide or zinc ores. Natural
weathering of minerals releases small amounts of cadmium to the environment,
but human activities are responsible for the majority of cadmium releases.
Anthropogenic sources of cadmium include releases from mining and smelting,
fuel combustion, manufacture and use of phosphate fertilizer, application of
sewage sludges, waste incineration, and primary and
secondary metal production. |
Absorption of cadmium following inhalation
exposure varies depending on particle size. Large particles (>10 microns
in diameter) tend to be deposited in the upper airway, while smaller
particles (about 0.1 microns) tend to penetrate into the alveoli. Cadmium bioaccumulates
in mammals, particularly in the kidney and liver. Epidemiological studies
have revealed an association between nonmalignant pulmonary diseases and
inhalation of cadmium. It is also suspected that chronic exposure to cadmium
produces anemia, sensory loss (particularly smell), and immunosuppression in
humans. The IARC has classified cadmium as a “group 1 known carcinogen". |
Chromium VI |
Chromium is a naturally occurring metal present
in low concentrations in the earth's crust. Chromium (VI) is the second most
stable chromium compound, after chromium (III). Natural occurrence of
hexavalent chromium (chromium [VI]) is infrequent; it occurs in nature in the
rare mineral crocoite (PbCrO4). It is primarily produced from anthropogenic
sources. Chromium (VI) is used extensively in industry, mainly for plating
metals such as stainless and alloy steels and aluminum. It is also used as an
additive in cleansing agents, paints, catalysts, fungicides, and wood
preservatives. |
Hexavalent chromium compounds are strong
oxidizing agents and are severely irritating and corrosive. Acute inhalation
exposure to chromium (VI) may cause asthma attacks in sensitive individuals;
concentrations at which these effects occur were not described. Acute
inhalation exposure to chromium fumes may also cause fever, chills, and
muscle aches. Chronic inhalation of dust containing chromium (VI)
concentrations may cause respiratory irritation, emphysema, chronic
bronchitis, and other respiratory conditions. USEPA has classified inhaled
chromium (VI) as Group A - Human Carcinogen.
The IARC has classified chromium(VI) as a “group 1 known carcinogen". |
Chrysene |
Chrysene is present as a major component of the
total content of polynuclear aromatic compounds in the
environment. Human exposure to chrysene occurs primarily through the smoking
of tobacco, inhalation of polluted air. |
Inhalation of Chrysene may irritate the nose and
throat causing coughing and wheezing as acute effects. Chrysene is classified
as "group 2B probable human carcinogen" as it has shown to cause
liver and lung cancer in animals. The IARC has classified chrysene as a
“group 2B Possibly carcinogenic to humans". |
Copper |
Copper is a reddish metal that occurs naturally
in rock, soil, water, sediment, and, at low levels, air. Copper can enter the
environment through releases from the mining of copper, and from factories
that make or use copper metal or copper compounds. Copper can also enter the
environment through waste dumps, domestic waste water, combustion of fossil
fuels and wastes, wood production, phosphate fertilizer production, and
natural sources. |
In humans, copper is a respiratory irritant.
Workers exposed to copper dust report a number of symptoms that are
suggestive of respiratory irritation, including coughing, sneezing, thoracic
pain, and runny nose. Copper is also considered the etiologic agent in the
occupational disease referred to as “vineyard sprayer’s lung”. USEPA has not
yet classified copper as a human carcinogen. |
Dibenz(a,h)anthracene |
Dibenz(a,h)anthracene is a specie of Polycyclic aromatic
hydrocarbons (PAHs). PAHs are a group of chemicals that are formed during the
incomplete burning of coal, oil, gas, wood, garbage, or other organic
substances, such as tobacco and charbroiled meat. PAHs usually occur
naturally, but they can be manufactured as individual compounds for research
purposes. |
Studies of people show that individuals exposed
by breathing or skin contact for long periods to mixtures that contain PAHs and
other compounds can develop cancer. United States Department of Health and
Human Services (USHHS) has determined that |
Diesel Particulate Matters |
Diesel PM is formed primarily through the
incomplete combustion of diesel fuel. PM in diesel exhaust can be emitted
from on- and off-road vehicles, stationary area sources, and stationary point
sources. Typical diesel exhaust particles have diameters ranging from 0.1 to
0.25 micrometers (μm). The particles are
mainly aggregates of spherical elemental carbon particles coated with organic
and inorganic |
The primary route by which humans are exposed to
diesel exhaust PM is via inhalation. Numerous epidemiological and clinical
studies have conclusively shown that exposure to PM in diesel emissions is
associated with increases in respiratory illnesses such as bronchitis,
emphysema and asthma, as well as premature deaths from cardio-pulmonary
disorders. Diesel exhaust is classified as Group 1 “Carcinogenic to human” as
to its carcinogenicity to humans" by IARC. |
Ethylbenzene |
Ethylbenzene is a colourless liquid with an aromatic odour.
It is used primarily in the production of styrene. It is also used as a
solvent, as a constituent of asphalt and naphtha, and in fuels. It may occur
naturally, as it has been found in orange peel, parsley leaves, dried legumes
and other foodstuffs. |
Short-term inhalation exposure of people to Ethylbenzene can cause respiratory effects, such as
throat irritation and chest constriction, irritation of the eyes, and
neurological effects such as dizziness. Long-term inhalation exposure of
people to Ethylbenzene may results effects on the
blood. IARC has classified ethylbenzene as a
"group 2B Possibly carcinogenic to humans". |
Formaldehyde |
At room temperature, formaldehyde is a colorless,
flammable gas that has a distinct, pungent smell. Formaldehyde is a product of
incomplete combustion and is emitted into the air by burning wood, coal,
kerosene, and natural gas, by automobiles, and by cigarettes; it is also a
naturally occurring substance. Formaldehyde can be released to soil, water,
and air by industrial sources and can off-gas from materials made with it.
Humans can be exposed to formaldehyde through inhalation of contaminated air
and smog. |
Low levels of formaldehyde can cause irritation
of the eyes, nose, throat, and skin. Chronic exposure leads to cancer of the nasopharynx and leukemia. The IARC classifies
formaldehyde as a “group 1 carcinogen”. |
Indeno(1,2,3-cd)pyrene |
Indeno(1,2,3-cd)pyrene belongs to aromatic hydrocarbon compounds (PAHs),
which are formed primarily from combustion and are present in the atmosphere
in particulate form. Sources of air
emissions are diverse and include cigarette smoke, vehicle exhaust, home
heating, laying tar, and grilling meat. |
No reports of effects to humans following acute
exposure to polycyclic organic matter (POM) are available. Epidemiologic
studies have reported an increase in lung cancer in humans exposed to coke
oven emission, roofing tar emissions, and cigarette smoke. Each of these
mixtures contains a number of POM compounds. USEPA has classified Indeno(1,2,3-cd)pyreneas "group B2, probable human
carcinogens". |
Isopropylbenzene (cumene) |
Cumene is a
water-insoluble petrochemical used in the manufacture of several chemicals,
including phenol and acetone. It readily volatilizes into the atmosphere from
water and dry soil/sediments and to undergo biodegradation in water and soil. |
Short-term inhalation exposure to cumene may cause headaches, dizziness, drowsiness, slight
incoordination, and unconsciousness in humans. Cumene
has a potent central nervous system (CNS) depressant action characterized by
a slow induction period and long duration of narcotic effects in animals. Cumene is a skin and eye irritant. No information is
available on the chronic, reproductive, developmental, or carcinogenic
effects of cumene in humans. USEPA has classified cumene as a Group D, not classifiable as to human
carcinogenicity. |
Lead |
Lead is a naturally occurring, soft, bluish-gray
heavy metal. Due to its abundance, low cost and physical properties (low
melting point, corrosion resistance, waterproof nature and malleability) lead
and lead compounds have been utilized in a variety of products including
cable covers, petrol (gasoline), paint, plastics, pesticides, solder, etc.
This widespread use of lead has caused extensive environmental contamination
and health problems in many parts of the world. |
Short-term inhalation exposure of people to high
levels of lead can cause gastrointestinal disturbances (anorexia, nausea, vomiting, abdominal pain), hepatic and renal damage, hypertension
and neurological effects (malaise, drowsiness, encephalopathy) that may lead
to convulsions and death. Long-term inhalation exposure of lead commonly
causes haematological effects, such as anaemia, or neurological disturbances. There is some evidence
that long-term occupational exposure to lead may contribute to the
development of cancer. IARC has classified inorganic lead compounds as a
"Group 2A Probably carcinogenic to humans". |
Manganese |
Manganese is naturally ubiquitous in the environment.
Manganese is essential for normal physiologic functioning in humans and
animals, and exposure to low levels of manganese in the diet is considered to
be nutritionally essential in humans. Metallic manganese is used primarily in
steel production to improve hardness, stiffness, and strength. Manganese
compounds have a variety of uses. Manganese dioxide is used in the production
of dry-cell batteries, matches, fireworks, etc. |
Long-term inhalation exposure of people to manganese
results primarily in effects on the nervous system. Long-term inhalation
exposure of people to high levels may result in a syndrome called manganism and typically begins with feelings of weakness
and lethargy and progresses to other symptoms such as gait disturbances,
clumsiness, and psychological disturbances. USEPA has classified manganese as
a Group D, not classifiable as to carcinogenicity in humans. |
Methyl alcohol (Methanol) |
Methanol is a colorless liquid that may explode
when exposed to an open flame. It is primarily used as an industrial solvent
for inks, resins, adhesives, and dyes. It is also used as a solvent in the
manufacture, antifreeze for automotive radiators, ingredient of gasoline,
etc. Natural emission sources of methanol include volcanic gases, vegetation,
microbes, and insects; methanol is also formed during biological
decomposition of biological wastes, sewage, and sludge. |
Short-term inhalation exposure of people to high
levels of methanol may result in visual disturbances, such as blurred or
dimness of vision, leading to blindness. Long-term inhalation exposure to
methanol may result in headache, dizziness blurred vision, and blindness in
humans. Neurological damage, specifically permanent motor dysfunction, may
also result. No information is available on the carcinogenic effects of
methanol in humans or animals. USEPA has not classified methanol with respect
to carcinogenicity. |
Xylene |
Xylene is a colorless, sweet-smelling liquid that
catches on fire easily. It occurs naturally in petroleum and coal tar.
Chemical industries produce xylene from petroleum. Xylene is used as a
solvent and in the printing, rubber, and leather industries. It is also used
as a cleaning agent, a thinner for paint, and in paints and varnishes. It is
found in small amounts in airplane fuel and gasoline. |
Short-term exposure of people to high levels of
xylene can cause irritation of the skin, eyes, nose, and throat; difficulty
in breathing; impaired function of the lungs; delayed response to a visual
stimulus; impaired memory; stomach discomfort; and possible changes in the
liver and kidneys. Both short- and long-term exposure to high concentrations
of xylene can also cause a number of effects on the nervous system, such as
headaches, lack of muscle coordination, dizziness, confusion, and changes in
one's sense of balance. Some people exposed to very high levels of xylene for
a short period of time have died. USEPA has classified mixed xylenes as a
Group D, not classifiable as to human carcinogenicity. |
Naphthalene |
Naphthalene is a white solid with the odour of mothballs or tar, and is found naturally in
fuels when they are burned. Burning tobacco or wood also produces naphthalene.
The major commercial use of naphthalene is in the manufacture of polyvinyl
chloride (PVC) plastics. Naphthalene is released into the air through the
burning of tobacco, wood, oil and coal. |
Exposure to large amounts of naphthalene may
damage or destroy some red blood cells. This condition is called hemolytic
anemia, with symptoms including fatigue, lack of appetite, restlessness, and
pale skin. Exposure to large amounts of naphthalene may also cause nausea,
vomiting, diarrhea, blood in the urine, and a yellow color to the skin. The
IARC has classified naphthalene as a "group 2B Possibly carcinogenic to
humans". |
n-Hexane |
n-Hexane is a
chemical made from crude oil. It is a colorless liquid with a slightly
unpleasant odor. It evaporates very easily into the air and dissolves only
slightly in water. Pure n-hexane is used in laboratories. Most of the
n-hexane used in industry is mixed with similar chemicals in products known
as solvents. The major use for solvents containing n-hexane is to extract
vegetable oils from crops such as soybeans. They are also used as cleaning
agents in the printing, textile, furniture, and shoemaking industries. |
Long-term inhalation exposure of humans to
n-hexane results primarily in effects on the nervous system. Feeling of
numbness in feet and hands, followed by muscle weakness in the feet and lower
legs were reported in several studies of workers occupationally exposed air
containing high concentrations of n-hexane. USEPA has classified hexane as a
Group D, not classifiable as to human carcinogenicity. |
Nickel |
Nickel is a hard, silvery-white metal. It is a
natural element of the earth's crust, therefore, small amounts are found in
food, water, soil, and air. Nickel can be combined with other metals, such as
iron, copper, chromium, and zinc, to form alloys. These alloys are used to
make coins, jewelry, and items such as valves and heat exchangers. Most
nickel is used to make stainless steel. |
Short-term inhalation exposure of people to an
extremely high level of nickel suffered severe damage to the lungs and
kidneys. Long-term inhalation exposure of people to nickel results in
respiratory effects, including a type of asthma specific to nickel, decreased
lung function, and bronchitis. The IARC has classified nickel compounds as
"Group 1 Carcinogenic to humans". |
Phenol (carbolic acid) |
Phenol has a wide range of uses, including in the
preparation of phenolic and epoxy resins, nylon-6, selective solvents for
refining lubricating oils, adipic acid,
phenolphthalein, etc. |
Short-term inhalation exposure of people to high
level of Phenol can cause irregular breathing, muscle weakness and
respiratory. Anorexia, progressive weight loss and diarrhea have been
reported in chronically exposed humans.
Gastrointestinal irritation and blood and liver effects have also been
reported. In one study, muscle pain, weakness, enlarged liver and elevated
levels of liver enzymes were found in an individual after long-term
inhalation and dermal exposure to phenol and a few other chemicals. USEPA has
classified phenol as a Group D, not classifiable as to human carcinogenicity,
based on a lack of data concerning carcinogenic effects in humans and
animals. |
Propionaldehyde |
Propionaldehyde is a colorless,
flammable liquid with a suffocating fruity odour. Propionaldehyde is released to the atmosphere via the
combustion of wood, gasoline, diesel fuel, and polyethylene. Municipal waste
incinerators can release it to ambient air.
|
The vapor may cause respiratory irritation but is
not a strong enough irritant of eyes or respiratory tract to be considered
significant factor in smog. USEPA has not classified propionaldehyde
for carcinogenicity. IARC has classified it as "group 3 Not classifiable
as to its carcinogenicity to humans". |
Styrene |
Styrene is a colourless,
viscous liquid with a pungent odour. It is used
predominately in the production of polystyrene plastics and resins. It is
also used as an intermediate in the synthesis of materials used for ion
exchange resins and to produce copolymers. Indoor air is the principal route
of styrene exposure for the general population, occupational exposure to
styrene occurs in the reinforced plastics industry and polystyrene factories. |
Short-term exposure to styrene in humans results
in respiratory effects, such as mucous membrane irritation, eye irritation,
and gastrointestinal effects. Long-term exposure to styrene in humans results
in effects on the CNS, with symptoms such as headache, fatigue, weakness,
depression, CNS dysfunction and on the blood. IARC classified styrene as
"Group 2B Possibly carcinogenic to humans". |
TCDD |
TCDD is not intentionally produced by industry.
It can be inadvertently produced in very small amounts as an impurity during the
incineration of municipal and industrial wastes and during the manufacture of
certain chemicals. It may be formed during the chlorine bleaching process
used by pulp and paper mills, and as a by-product from the manufacture of
certain chlorinated organic chemicals, such as chlorinated phenols. It is
primarily released to the environment during the combustion of fossil fuels
(including motor vehicles) and wood, and during incineration processes. |
Short-term inhalation exposure of people to TCDD
can cause chloracne, and a severe acne-like
condition that can develop within months of first exposure. Chronic effects
(non-cancer) from TCDD of inhalation in humans have not been reported in the
literature. Human studies, primarily of
workers occupationally exposed to 2,3,7,8-TCDD by
inhalation, have found an association between 2,3,7,8-TCDD and lung cancer,
soft-tissue sarcomas, lymphomas, and stomach carcinomas. IARC has classified
it as "Group 1 Carcinogenic to humans". |
Toluene |
Toluene is a clear, colorless, inflammable liquid
with benzene-like odour. It is used as a
high-octane blending stock in gasoline; as a solvent for paints and coatings,
gums, resins, oils, rubber and adhesives; and as an intermediate in the
preparation of many chemicals, dyes, pharmaceuticals, detergents and
explosives. It is released into the atmosphere principally from the
volatilization of petroleum fuels and toluene-based solvents and thinners and
in motor vehicle exhaust. It is also present in emissions from volcanoes,
forest fires and crude oil. |
The central nervous system (CNS) is the primary
target organ for toluene toxicity in both humans and animals for acute and
chronic exposures. CNS dysfunction and narcosis have been frequently observed
in humans acutely exposed to low or moderate levels of toluene by inhalation;
symptoms include fatigue, sleepiness, headaches, and nausea. CNS depression
and death have occurred at higher levels of exposure. Long-term inhalation
exposure of humans to toluene causes irritation of the upper respiratory
tract and eyes. Under the Guidelines for Carcinogen Risk Assessments (USEPA,
2005), the USEPA considers that there is inadequate information to assess the
carcinogenic potential of toluene. |
Non-carcinogenic Health Risk of TAP
Table 17.2.23: Basis of risk values in different guidelines
Risk value |
Description |
WHO non-carcinogenic chemicals guideline (WHO) |
The air quality guidelines for non-carcinogenic pollutants can only be applied if the averaging times are specified. The averaging time associated with a guideline value depends on the type of effects that are caused by short-term exposure producing acute effects, or long term exposure producing chronic effects. Typical averaging times are 24 hours for acute exposure and one year for chronic health effects. |
USEPA non-cancer risk value (USEPA-IRIS; Scorecard) |
The non-cancer risk values from the USEPA are reference doses or concentrations and are estimates of the daily exposure to the human population (including subgroups) that is likely without an appreciable risk of deleterious effects over a lifetime. |
Minimum risk level (US – ATSDR) |
ATSDR developed
minimum risk level. It is an estimate of the daily human exposure to a
hazardous substance that is likely to be without appreciating risk of
adverse, non-cancer health effect over a specified duration of period.
According to its definition, acute-duration means exposure less than 14 days.
Chronic duration means exposure longer than 1 year. |
Acute reference exposure levels (CEPA-OEHHA) |
OEHHA developed acute REL for assessing potential non-cancer health impacts for short-term, generally one-hour peak exposures to facility emissions. By definition, an acute REL is an exposure that is unlikely to cause adverse health effects in a human population, including sensitive subgroups, exposed to that concentration for the specified exposure duration on an intermittent basis. |
Chronic reference exposure levels (CEPA – OEHHA) |
OEHHA developed chronic RfC for assessing non-cancer health impact from long term exposure. A chronic RfC is a concentration level at or below which no adverse health effects are anticipated due to long term exposure. Long term exposure for these purposes has been defined as 12% of a lifetime, or 8.4 years for humans. |
If ECc
≤ RfC, adverse
chronic
non-cancer health effects are not
anticipated.
If ECST ≤ AV, adverse acute health
effects are not anticipated.
Carcinogenic Health Risk of TAP
Table 17.2.24: Summary of key literature to establish the carcinogenic classification and unit risk for cancer
Purpose |
Key Literature |
Carcinogenic classification |
· WHO · USEPA – IRIS · CEPA –OEHHA · California Air Resources (CARB) -
California Air Toxic Programme · IARC |
Unit risk for cancer |
· WHO – Air Quality Guideline · USEPA – IRIS · CEPA – OEHHA |
Hence,
Cancer Riski = △ECL x IUR
Where:
△ECL = estimate of incremental
long-term inhalation exposure concentration (i.e. concentrations due to the Project less concentrations due to the
“business as usual” scenario under the existing 2RS) for a specific TAP;
IUR =
the corresponding inhalation unit risk
estimate for that TAP
Table17.2.25: Cancer risk guidelines
Risk value |
Description |
Cancer risks less than or equal to one in a million
(1x10-6) |
Negligible |
Cancer risks that fall in-between 1 x 10-4
and 1 x 10-6 |
Considered by the DAQ Risk Management Committee on a
case-by-case basis. Sources with risk falling within this range must take
steps to minimize the projected risk before a Pre-Construction Permit can be
issued. |
Cancer risks greater than or equal to one in ten
thousand (1x10-4) |
Unacceptable |
Table 17.2.26: Toxicity criteria of the acute, carcinogenic and chronic non-carcinogenic risks of the identified TAP
TAP |
IUR |
RfC |
AV |
|||
(per µg/m3) |
Source [1] |
(µg/m3) |
Source [1] |
(µg/m3) |
Source [1] |
|
1,3-butadiene |
3.00E-05 |
IRIS |
2 |
IRIS |
660 (1-hr) |
OEHHA |
Acetaldehyde |
2.20E-06 |
IRIS |
9 |
IRIS |
470
(1-hr) |
OEHHA |
Acrolein |
0.35[2] |
WHO |
7 (daily) |
ATSDR |
||
Arsenic |
1.50E-03 |
WHO |
0.015 |
OEHHA |
0.2 (1-hr) |
OEHHA |
Benz(a)anthracene |
1.10E-04 |
OEHHA |
||||
Benzene |
6.00E-06 |
WHO |
30 |
IRIS |
29 (daily) |
ATSDR |
Benzo(a)pyrene |
8.70E-02 |
WHO |
||||
Benzo(bk)fluoranthene |
1.10E-04 |
OEHHA |
||||
Beryllium |
2.40E-03 |
IRIS |
0.02 |
WHO |
|
|
Cadmium |
1.80E-03 |
IRIS |
0.01 |
ATSDR |
0.03 (daily) |
ATSDR |
Chromium VI |
4.00E-02 |
WHO |
0.1 |
IRIS |
0.3 (daily)[6] |
ATSDR |
Chrysene |
1.10E-05 |
OEHHA |
||||
Copper |
2.4 |
OEHHA |
100 (1-hr) |
OEHHA |
||
Dibenz(a,h)anthracene |
1.20E-03 |
OEHHA |
||||
Diesel
Particulate Matter |
3.00E-04 |
OEHHA |
5 |
IRIS [3] |
||
Ethylbenzene |
2.50E-06 |
OEHHA |
1,000 |
IRIS |
21,700 (daily) |
ATSDR |
Formaldehyde |
1.30E-05 |
IRIS |
100 [4] |
WHO |
100 (30-min) |
WHO |
Indeno(1,2,3-cd)pyrene |
1.10E-04 |
OEHHA |
||||
Isopropylbenzene (cumene) |
400 |
IRIS |
||||
Lead |
1.20E-05 |
OEHHA |
0.5 |
WHO |
|
|
Manganese |
0.150 |
WHO |
||||
Methyl alcohol
(Methanol) |
20,000 |
IRIS |
2,8000 (1-hr) |
OEHHA |
||
Xylene |
100 |
IRIS |
8,820 (daily) |
ATSDR |
||
Naphthalene |
3.40E-05 |
OEHAA |
10 |
WHO |
|
|
n-Hexane |
700 |
IRIS |
|
|
||
Nickel |
3.80E-04 |
WHO |
0.09 |
ATSDR |
0.2
(daily) |
ATSDR |
Phenol (carbolic
acid) |
200 |
OEHHA |
5,800 (1-hr) |
OEHHA |
||
Propionaldehyde |
8 |
IRIS |
|
|
||
Styrene |
1,000 |
IRIS |
21,630 [5] (daily) |
ATSDR |
||
TCDD |
3.80E+01 |
OEHHA |
||||
Toluene |
5,000 |
IRIS |
3,750 (daily) |
ASTDR |
Notes:
[1] The hierarchy in
selecting information source is WHO > USEPA – IRIS > US – ATSDR >
CARB-OEHAA.
[2] Concise
International Chemical Assessment Document 43, WHO 2002. This value was further
supported by the updated RfC values (as of Oct 2013)
from OEHHA (http://oehha.org/air/allrels.html).
[3] Diesel Particulate Matter (DPM) is
the particulate
component of diesel exhaust.
[4] According
to WHO guidelines for indoor air quality: Selected pollutants, 2010, this
short-term guideline would also prevent effects on lung function as well as long-term
health effects, including nasopharyngeal cancer and myeloid leukaemia. Hence,
it was adopted as reference concentration.
[5] According to WHO Air Quality Guidelines for Europe, 2000,
the air quality guideline for styrene was based on odour detection threshold
level of 70 μg/m3
(30-minute average). Hence, it is not selected as acute risk level.
[6] Based on intermediate inhalation minimal risk level on
particulates phase.
Health Risk of Criteria Pollutants
Short-Term Health Effect
Table 17.2.27: Percentage of excess risk (95% of confidence interval) of short-term mortalities and morbidities attributable to a 10 µg/m3 increase in air pollutant concentrations (for all ages)
Air Pollutant |
All-cause Mortality |
Cardio- vascular Mortality |
Respiratory Mortality |
Cardio- vascular Diseases |
Respiratory Diseases |
Hong Kong [1] |
|||||
NO2 |
1.03
(0.69-1.37) |
1.38
(0.75-2.01) |
1.41
(0.67-2.15) |
1.00
(0.73-1.26) |
0.75 (0.50 -
1.00) |
PM10 |
0.51
(0.23-0.80) |
0.63
(0.11-1.16) |
0.69 (0.08-1.31) |
0.58
(0.36-0.80) |
0.60
(0.40-0.80) |
SO2 |
0.91
(0.40-1.42) |
1.23
(0.27-2.21) |
1.31
(0.21-2.43) |
0.98
(0.53-1.39) |
0.13
(-0.24-0.50) |
Note: [1] Wong, C.M., et al., 2010.
Long-Term Health Effect
Table 17.2.28: Percentage of excess risk (95% of confidence interval) of long-term mortalities attributable to air pollutants
Air Pollutant |
All-cause Mortality |
Cardiopulmonary Mortality |
Lung Cancer Mortality |
NO2 |
Effects cannot be separated from PM10 or PM2.5 effects [2] |
||
PM10 [3]
[4] |
5 (Not Statistically
Significant) |
16.3 (Not
Statistically Significant) |
28.5 (Not
Statistically Significant) |
PM2.5 [5] |
4 (1-8)[6] |
6 (2-10)[6] |
8 (1-16)[6] |
SO2 |
WHO recommends a 24 hr AQG of 20 µg/m3. No annual AQG is recommended. |
Notes:
[1] % excess risks are expressed as per 10 µg/m3 increase in air pollutant concentrations.
[2] It is difficult to separate the long-term effects of NO2 from PM and other traffic generated fumes. WHO maintains a long-term Air Quality Guideline of 40 µg/m3.
[3] McDonnell WF et al. Relationships of mortality with the fine and coarse fractions of long-term ambient PM10 concentrations in nonsmokers. Journal of Exposure Analysis and Environmental Epidemiology 2000;10:427-436;
[4] Evidence for a separate RR of mortality for long-term exposure to PM10 is insufficient, but RRs for short-term exposure are well-documented.
[5] ACS study by Pope, A.C., et al., Lung Cancer, Cardiopulmonary Mortality, and Long-term Exposure to Fine Particulate Air Pollution, Journal of the American Medical Association, 2002.
[6] Mean value was adopted as the excess risk factor for health impact assessment according to international practices.
ˇ Attributable proportion (AP) = [(RRc – 1) x Pc] / [RRc x Pc]
ˇ Ie (Incidence or number of cases
attributable to exposure per 10 mg/m3 increase in
pollutants) = I x AP;
ˇ Incidence or mortality rate
attributable to air pollution = Ie /
current HK population
ˇ No. of hospital admissions or premature
deaths attributed to
air pollution in representative human receptors in the future = Future
population in representative human receptors x Ie / current HK population x 0.1 x incremental
change in the concentration of criteria pollutants (i.e. the difference between
the concentration of air pollutants in 3RS and 2RS)
Table 17.2.29: Summary of parameters for hospital illnesses health outcome
Health Outcome |
RR (per 10µg/m3) |
AP (per 10µg/m3) |
I [5] |
Ie [1] (per 10µg/m3) |
|
Short-term hospital illnesses effects of NO2 |
Cardiovascular
[2] & [3] |
1.0100 |
0.00990 |
155,299 |
1,537.6 |
Respiratory
[2] & [4] |
1.0075 |
0.00744 |
169,071 |
1,258.6 |
|
Short-term hospital illnesses effects of RSP |
Cardiovascular
[2] & [3] |
1.0058 |
0.00577 |
155,299 |
895.5 |
Respiratory
[2] & [4] |
1.0060 |
0.00596 |
169,071 |
1,008.4 |
|
Short-term hospital illnesses effects of SO2 |
Cardiovascular
[2] & [3] |
1.0098 |
0.00970 |
155,299 |
1,507.2 |
Respiratory
[2] & [4] |
1.0013 |
0.00130 |
169,071 |
219.5 |
[1] Ie = Total population in HK in mid-2012 = 7,154,600 (Census and Statistics Department).
[2] Wong C.M. et al, 2010.
[3] In HK in 2012, numbers of in-patient
discharges of cardiovascular diseases in hospital (ICD10: I00-I99) =
155299
(Department of Health: http://www.dh.gov.hk/english/pub_rec/pub_rec_ar/pdf/1213/supplementary_table2012.pdf).
[4]
In HK in 2012, numbers of
in-patient discharges of respiratory diseases in hospital (ICD10: J00-J99) =
169071
(Department of Health:
http://www.dh.gov.hk/english/pub_rec/pub_rec_ar/pdf/1213/supplementary_table2012.pdf).
[5] Numbers of in-patient discharges in hospitals for cardiovascular or respiratory disease.
Table 17.2.30: Summary of parameters for premature death mortality health outcome
Health Outcome |
RR (per 10µg/m3) |
AP (per 10µg/m3) |
I[7] |
Ie [1] (per 10µg/m3) |
|
Long-term mortality effects of FSP |
All-causes mortality [2] & [3] |
1.0400 |
0.03846 |
42,017 |
1,616.0 |
Cardiopulmonary [2] & [4] |
1.0600 |
0.05660 |
19,952 |
1,129.4 |
|
Malignant Neoplasm of Trachea, Bronchus and Lung [2] & [5] |
1.0800 |
0.07407 |
3,893 |
288.4 |
|
Short-term mortality effects of NO2 |
All-causes mortality [3] & [4] |
1.0103 |
0.01019 |
42,017 |
428.4 |
Cardiovascular [4] & [6] |
1.0138 |
0.01361 |
10,320 |
140.5 |
|
Respiratory [4] & [6] |
1.0141 |
0.01390 |
9,632 |
133.9 |
|
Short-term mortality effects of RSP |
All-causes mortality [3] & [4] |
1.0051 |
0.00507 |
42,017 |
213.2 |
Cardiovascular [4] & [6] |
1.0063 |
0.00626 |
10,320 |
64.6 |
|
Respiratory [4] & [6] |
1.0069 |
0.00685 |
9,632 |
66.0 |
|
Short-term mortality effects of SO2 |
All-causes mortality [3] & [4] |
1.0091 |
0.00902 |
42,017 |
378.9 |
Cardiovascular [4] & [6] |
1.0123 |
0.01215 |
10,320 |
125.4 |
|
Respiratory [4] & [6] |
1.0131 |
0.01293 |
9632 |
124.5 |
[1] Total population in HK in 2012 = 7,154,600 (Census and Statistics Department).
[2] ACS study by Pope et al, 2002.
[3] In 2012, Numbers of deaths in hospital for all-causes in HK = 43672; numbers of deaths in hospital from external causes of morbidity and mortality = 1655. Hence, total numbers of natural deaths in hospital = 43672 - 1655 = 42017.
(Department of Health: http://www.dh.gov.hk/english/pub_rec/pub_rec_ar/pdf/1213/supplementary_table2012.pdf)
[4] In 2012, numbers of deaths in hospital from cardiovascular diseases (ICD10: I00-I99) in HK = 10320; numbers of deaths in hospital from respiratory diseases (ICD10: J00-J99) = 9632. Total cardiopulmonary deaths in HK in 2012= 10320 + 9632 = 19952.
[5] Numbers of deaths in hospital from malignant neoplasm of trachea, bronchus and lung in HK in 2012 (ICD10: C33-C34) = 3893 (Department of Health: http://www.dh.gov.hk/english/pub_rec/pub_rec_ar/pdf/1213/supplementary_table2012.pdf)
[6] Wong C.M. et al, 2010.
[7] Numbers of deaths in hospitals for cardiovascular or respiratory disease.
Toxic Air Pollutants
Chronic
Non-carcinogenic Health Risk
Table 17.2.31: Maximum
predicted cumulative annual average TAP concentrations for 3RS (µg/m3)
Major Area |
Criteria |
Siu Ho Wan |
Sha Lo Wan |
San Shek Wan |
San Tau |
Sham Wat |
Tung Chung |
1,3-butadiene |
2 |
3.35E-01 (Yes) |
4.06E-01 (Yes) |
3.54E-01 (Yes) |
3.70E-01 (Yes) |
3.35E-01 (Yes) |
3.41E-01 (Yes) |
Acetaldehyde |
9 |
1.52E+00 (Yes) |
1.72E+00 (Yes) |
1.58E+00 (Yes) |
1.62E+00 (Yes) |
1.52E+00 (Yes) |
1.54E+00 (Yes) |
Acrolein |
0.35 |
2.37E-02 (Yes) |
1.14E-01 (Yes) |
4.79E-02 (Yes) |
6.56E-02 (Yes) |
2.39E-02 (Yes) |
2.95E-02 (Yes) |
Benzene |
30 |
1.51E+00 (Yes) |
1.51E+00 (Yes) |
1.44E+00 (Yes) |
1.47E+00 (Yes) |
1.41E+00 (Yes) |
1.50E+00 (Yes) |
Ethylbenzene |
1000 |
1.70E+00 (Yes) |
1.71E+00 (Yes) |
1.71E+00 (Yes) |
1.71E+00 (Yes) |
1.71E+00 (Yes) |
1.71E+00 (Yes) |
Formaldehyde |
100 |
3.69E+00 (Yes) |
4.26E+00 (Yes) |
3.85E+00 (Yes) |
3.98E+00 (Yes) |
3.70E+00 (Yes) |
3.74E+00 (Yes) |
Isopropylbenzene (cumene) |
400 |
1.18E-01 (Yes) |
1.19E-01 (Yes) |
1.18E-01 (Yes) |
1.18E-01 (Yes) |
1.18E-01 (Yes) |
1.18E-01 (Yes) |
Methyl alcohol (Methanol) [1] |
20000 |
9.44E-03 (Yes) |
7.09E-02 (Yes) |
2.58E-02 (Yes) |
3.74E-02 (Yes) |
9.43E-03 (Yes) |
1.30E-02 (Yes) |
Xylene (Total) |
100 |
4.98E+00 (Yes) |
5.00E+00 (Yes) |
4.99E+00 (Yes) |
4.99E+00 (Yes) |
4.98E+00 (Yes) |
4.98E+00 (Yes) |
n-Hexane |
700 |
1.37E+00 (Yes) |
1.39E+00 (Yes) |
1.37E+00 (Yes) |
1.42E+00 (Yes) |
1.37E+00 (Yes) |
1.40E+00 (Yes) |
Naphthalene |
10 |
7.65E-01 (Yes) |
7.99E-01 (Yes) |
7.74E-01 (Yes) |
7.86E-01 (Yes) |
7.65E-01 (Yes) |
7.85E-01 (Yes) |
Phenol (carbolic acid) [1] |
200 |
3.80E-03 (Yes) |
2.85E-02 (Yes) |
1.04E-02 (Yes) |
1.51E-02 (Yes) |
3.79E-03 (Yes) |
5.24E-03 (Yes) |
Propionaldehyde |
8 |
1.79E-01 (Yes) |
2.06E-01 (Yes) |
1.86E-01 (Yes) |
1.92E-01 (Yes) |
1.79E-01 (Yes) |
1.81E-01 (Yes) |
Styrene |
1000 |
2.13E-01 (Yes) |
2.23E-01 (Yes) |
2.16E-01 (Yes) |
2.17E-01 (Yes) |
2.13E-01 (Yes) |
2.13E-01 (Yes) |
Toluene |
5000 |
6.64E+00 (Yes) |
6.70E+00 (Yes) |
6.66E+00 (Yes) |
6.67E+00 (Yes) |
6.64E+00 (Yes) |
6.65E+00 (Yes) |
Arsenic |
0.015 |
5.00E-03 (Yes) |
5.02E-03 (Yes) |
5.01E-03 (Yes) |
5.01E-03 (Yes) |
5.00E-03 (Yes) |
5.00E-03 (Yes) |
Beryllium |
0.02 |
4.02E-05 (Yes) |
4.12E-05 (Yes) |
4.04E-05 (Yes) |
4.12E-05 (Yes) |
4.02E-05 (Yes) |
4.05E-05 (Yes) |
Cadmium |
0.01 |
1.32E-03 (Yes) |
1.32E-03 (Yes) |
1.32E-03 (Yes) |
1.32E-03 (Yes) |
1.32E-03 (Yes) |
1.32E-03 (Yes) |
Chromium VI |
0.1 |
2.61E-03 (Yes) |
2.74E-03 (Yes) |
2.64E-03 (Yes) |
2.65E-03 (Yes) |
2.61E-03 (Yes) |
2.61E-03 (Yes) |
Copper |
2.4 |
6.07E-02 (Yes) |
6.23E-02 (Yes) |
6.11E-02 (Yes) |
6.12E-02 (Yes) |
6.07E-02 (Yes) |
6.07E-02 (Yes) |
Diesel Particulate Matters |
5 |
2.66E+00 (Yes) |
3.17E+00 (Yes) |
2.74E+00 (Yes) |
2.93E+00 (Yes) |
2.62E+00 (Yes) |
3.03E+00 (Yes) |
Lead |
0.5 |
5.00E-02 (Yes) |
5.02E-02 (Yes) |
5.01E-02 (Yes) |
5.01E-02 (Yes) |
5.00E-02 (Yes) |
5.00E-02 (Yes) |
Manganese |
0.15 |
2.06E-02 (Yes) |
2.09E-02 (Yes) |
2.07E-02 (Yes) |
2.07E-02 (Yes) |
2.06E-02 (Yes) |
2.06E-02 (Yes) |
Nickel |
0.09 |
4.76E-03 (Yes) |
4.92E-03 (Yes) |
4.80E-03 (Yes) |
4.82E-03 (Yes) |
4.76E-03 (Yes) |
4.77E-03 (Yes) |
Notes:
[1] Background
concentration in EPD’s Tung Chung Air Quality Monitoring Station and Central Western
Air Quality Monitoring Station is not available.
[2] For
predicted annual average TAP concentration, “Yes” refers to its compliance with
criteria and “No” refers to its non-compliance with criteria.
[3] Compliance against the criteria is shown in the ( ).
Table 17.2.32: Maximum incremental annual average TAP concentrations
(µg/m3)
Major Area |
Criteria |
Siu Ho Wan |
Sha Lo Wan |
San Shek Wan |
San Tau |
Sham Wat |
Tung Chung |
1,3-butadiene |
2 |
3.27E-03 (1.0%) |
1.22E-02 (3.1%) |
6.91E-03 (2.0%) |
4.98E-03 (1.4%) |
3.14E-03 (0.9%) |
3.49E-03 (1.0%) |
Acetaldehyde |
9 |
8.77E-03 (0.6%) |
3.17E-02 (1.9%) |
1.83E-02 (1.2%) |
1.28E-02 (0.8%) |
8.34E-03 (0.6%) |
9.39E-03 (0.6%) |
Acrolein |
0.35 |
4.45E-03 (23.2%) |
1.73E-02 (18.0%) |
9.52E-03 (24.8%) |
6.95E-03 (11.8%) |
4.35E-03 (22.3%) |
4.65E-03 (18.8%) |
Benzene |
30 |
3.68E-03 (0.3%) |
1.33E-02 (0.9%) |
7.70E-03 (0.5%) |
5.69E-03 (0.4%) |
3.37E-03 (0.2%) |
4.80E-03 (0.3%) |
Ethylbenzene |
1000 |
3.59E-04 (0.0%) |
1.49E-03 (0.1%) |
8.45E-04 (0.0%) |
6.07E-04 (0.0%) |
3.85E-04 (0.0%) |
3.76E-04 (0.0%) |
Formaldehyde |
100 |
2.52E-02 (0.7%) |
9.13E-02 (2.2%) |
5.27E-02 (1.4%) |
3.70E-02 (0.9%) |
2.40E-02 (0.7%) |
2.69E-02 (0.7%) |
Isopropylbenzene (cumene) |
400 |
7.37E-06 (0.0%) |
3.16E-05 (0.0%) |
1.86E-05 (0.0%) |
1.30E-05 (0.0%) |
8.42E-06 (0.0%) |
7.80E-06 (0.0%) |
Methyl alcohol (Methanol) |
20000 |
3.16E-03 (50.4%) |
1.26E-02 (21.7%) |
6.84E-03 (36.0%) |
5.04E-03 (15.6%) |
3.13E-03 (49.7%) |
3.28E-03 (33.7%) |
Xylene (Total) |
100 |
1.04E-03 (0.0%) |
4.41E-03 (0.1%) |
2.54E-03 (0.1%) |
1.81E-03 (0.0%) |
1.16E-03 (0.0%) |
1.10E-03 (0.0%) |
n-Hexane |
700 |
7.18E-04 (0.1%) |
3.72E-03 (0.3%) |
1.19E-03 (0.1%) |
7.59E-03 (0.5%) |
4.13E-04 (0.0%) |
5.00E-03 (0.4%) |
Naphthalene |
10 |
1.21E-03 (0. 2%) |
4.50E-03 (0.6%) |
2.52E-03 (0.3%) |
1.99E-03 (0.3%) |
1.14E-03 (0.1%) |
2.46E-03 (0. 3%) |
Phenol (carbolic acid) |
200 |
1.27E-03 (50.4%) |
5.08E-03 (21.7%) |
2.75E-03 (36.0%) |
2.03E-03 (15.6%) |
1.26E-03 (49.7%) |
1.32E-03 (33.7%) |
Propionaldehyde |
8 |
1.34E-03 (0.8%) |
5.25E-03 (2.6%) |
2.89E-03 (1.6%) |
2.02E-03 (1.1%) |
1.34E-03 (0.8%) |
1.37E-03 (0.8%) |
Styrene |
1000 |
5.23E-04 (0.2%) |
2.09E-03 (0.9%) |
1.13E-03 (0.5%) |
8.33E-04 (0.4%) |
5.18E-04 (0.2%) |
5.43E-04 (0.3%) |
Toluene |
5000 |
2.46E-03 (0.0%) |
1.11E-02 (0.2%) |
6.46E-03 (0.1%) |
6.38E-03 (0.1%) |
2.88E-03 (0.0%) |
4.03E-03 (0.1%) |
Arsenic |
0.015 |
7.03E-07 (0.0%) |
5.05E-07 (0.0%) |
1.13E-06 (0.0%) |
7.52E-07 (0.0%) |
7.50E-07 (0.0%) |
7.02E-07 (0.0%) |
Beryllium |
0.02 |
6.07E-08 (0.2%) |
1.88E-07 (0.5%) |
1.23E-07 (0.3%) |
2.38E-07 (0.6%) |
5.37E-08 (0.1%) |
8.53E-08 (0.2%) |
Cadmium |
0.01 |
6.07E-08 (0.0%) |
1.88E-07 (0.0%) |
1.23E-07 (0.0%) |
2.38E-07 (0.0%) |
5.37E-08 (0.0%) |
8.53E-08 (0.0%) |
Chromium VI |
0.1 |
2.17E-06 (0.1%) |
2.73E-05 (1.0%) |
2.90E-06 (0.1%) |
8.00E-06 (0.3%) |
2.11E-06 (0.1%) |
4.38E-06 (0.2%) |
Copper |
2.4 |
2.79E-05 (0.0%) |
3.42E-04 (0.6%) |
3.70E-05 (0.1%) |
9.98E-05 (0.2%) |
2.73E-05 (0.0%) |
5.53E-05 (0.1%) |
Diesel Particulate Matters |
5 |
7.36E-03 (0.3%) |
2.86E-02 (1.0%) |
1.63E-02 (0.6%) |
2.95E-02 (1.0%) |
5.99E-03 (0.2%) |
2.32E-02 (0.8%) |
Lead |
0.5 |
3.07E-06 (0.0%) |
3.61E-05 (0.1%) |
4.19E-06 (0.0%) |
1.09E-05 (0.0%) |
2.98E-06 (0.0%) |
5.93E-06 (0.0%) |
Manganese |
0.15 |
4.86E-06 (0.0%) |
5.51E-05 (0.3%) |
6.58E-06 (0.0%) |
1.66E-05 (0.1%) |
4.78E-06 (0.0%) |
9.15E-06 (0.0%) |
Nickel |
0.09 |
2.70E-06 (0.1%) |
3.27E-05 (0.7%) |
3.61E-06 (0.1%) |
9.65E-06 (0.2%) |
2.63E-06 (0.1%) |
5.31E-06 (0.1%) |
Note:
[1] Incremental percentage changes are listed in
the ( ).
Acute
Health Risk
Table 17.2.33: Maximum
predicted cumulative 1-hr / 24-hr average TAP concentrations for 3RS (µg/m3)
Major Area |
Criteria |
Airport Island |
BCF |
Siu Ho Wan |
Sha Lo Wan |
San Shek Wan |
San Tau |
Sham Wat |
Tung Chung |
Tuen Mun |
1,3-butadiene
|
660[1] |
4.03E+00
(Yes) |
2.81E+00
(Yes) |
2.23E+00
(Yes) |
3.71E+00
(Yes) |
2.90E+00
(Yes) |
3.40E+00
(Yes) |
2.53E+00
(Yes) |
3.19E+00
(Yes) |
2.32E+00
(Yes) |
Acetaldehyde
|
470[1] |
1.18E+01
(Yes) |
8.63E+00
(Yes) |
6.84E+00
(Yes) |
1.07E+01
(Yes) |
8.56E+00
(Yes) |
9.97E+00
(Yes) |
7.59E+00
(Yes) |
9.33E+00
(Yes) |
7.04E+00
(Yes) |
Acrolein |
7[2] |
1.10E+00
(Yes) |
8.86E-01
(Yes) |
2.47E-01
(Yes) |
8.04E-01
(Yes) |
4.31E-01
(Yes) |
8.05E-01
(Yes) |
2.81E-01
(Yes) |
4.04E-01
(Yes) |
3.78E-01
(Yes) |
Benzene |
29[2] |
3.14E+00
(Yes) |
3.35E+00
(Yes) |
4.40E+00
(Yes) |
2.92E+00
(Yes) |
2.59E+00
(Yes) |
2.93E+00
(Yes) |
2.47E+00
(Yes) |
2.93E+00
(Yes) |
2.52E+00
(Yes) |
Ethylbenzene |
21700[2] |
4.64E+00
(Yes) |
4.63E+00
(Yes) |
4.59E+00
(Yes) |
4.63E+00
(Yes) |
4.61E+00
(Yes) |
4.62E+00
(Yes) |
4.59E+00
(Yes) |
4.60E+00
(Yes) |
4.60E+00
(Yes) |
Formaldehyde
|
100[3] & [6] |
4.51E+01
(Yes) |
3.17E+01
(Yes) |
2.48E+01
(Yes) |
4.05E+01
(Yes) |
3.18E+01
(Yes) |
3.75E+01
(Yes) |
2.79E+01
(Yes) |
3.50E+01
(Yes) |
2.57E+01
(Yes) |
Methyl
alcohol (Methanol) |
28000[1] & [4] |
3.22E+00
(Yes) |
1.87E+00
(Yes) |
1.42E+00
(Yes) |
2.97E+00
(Yes) |
2.13E+00
(Yes) |
2.62E+00
(Yes) |
1.75E+00
(Yes) |
2.43E+00
(Yes) |
1.54E+00
(Yes) |
Xylene
(Total) |
8820[2] |
1.31E+01
(Yes) |
1.31E+01
(Yes) |
1.30E+01
(Yes) |
1.31E+01
(Yes) |
1.31E+01
(Yes) |
1.31E+01
(Yes) |
1.30E+01
(Yes) |
1.30E+01
(Yes) |
1.30E+01
(Yes) |
Phenol
(carbolic acid) |
5800[1] & [4] |
1.30E+00
(Yes) |
7.54E-01
(Yes) |
5.70E-01
(Yes) |
1.19E+00
(Yes) |
8.58E-01
(Yes) |
1.05E+00
(Yes) |
7.03E-01
(Yes) |
9.78E-01
(Yes) |
6.19E-01
(Yes) |
Styrene |
21630[2] |
1.43E+00
(Yes) |
1.40E+00
(Yes) |
1.33E+00
(Yes) |
1.39E+00
(Yes) |
1.35E+00
(Yes) |
1.39E+00
(Yes) |
1.33E+00
(Yes) |
1.35E+00
(Yes) |
1.34E+00
(Yes) |
Toluene |
3750[2] |
1.49E+01
(Yes) |
1.49E+01
(Yes) |
1.47E+01
(Yes) |
1.53E+01
(Yes) |
1.49E+01
(Yes) |
1.48E+01
(Yes) |
1.48E+01
(Yes) |
1.48E+01
(Yes) |
1.65E+01
(Yes) |
Arsenic |
0.2[1] |
2.21E-02
(Yes) |
2.15E-02
(Yes) |
2.14E-02
(Yes) |
2.19E-02
(Yes) |
2.16E-02
(Yes) |
2.16E-02
(Yes) |
2.15E-02
(Yes) |
2.16E-02
(Yes) |
8.58E-02
(Yes) |
Cadmium |
0.03[2] |
6.21E-03
(Yes) |
6.20E-03
(Yes) |
6.21E-03
(Yes) |
6.21E-03
(Yes) |
6.20E-03
(Yes) |
6.21E-03
(Yes) |
6.20E-03
(Yes) |
6.22E-03
(Yes) |
1.87E-02
(Yes) |
Chromium VI
|
0.3[2] |
8.55E-03
(Yes) |
8.72E-03
(Yes) |
8.21E-03
(Yes) |
9.13E-03
(Yes) |
8.49E-03
(Yes) |
8.82E-03
(Yes) |
8.19E-03
(Yes) |
8.30E-03
(Yes) |
2.03E-02
(Yes) |
Copper |
100[1] |
2.62E-01
(Yes) |
2.06E-01
(Yes) |
1.64E-01
(Yes) |
2.17E-01
(Yes) |
1.73E-01
(Yes) |
1.84E-01
(Yes) |
1.65E-01
(Yes) |
1.90E-01
(Yes) |
2.17E-01
(Yes) |
Nickel |
0.2[2] |
1.49E-02
(Yes) |
1.51E-02
(Yes) |
1.45E-02
(Yes) |
1.56E-02
(Yes) |
1.48E-02
(Yes) |
1.53E-02
(Yes) |
1.45E-02
(Yes) |
1.46E-02
(Yes) |
2.65E-02
(Yes) |
Notes:
[1] Based on hourly average concentration.
[2] Based on daily average concentration.
[3] Based on 30-min average concentration
[4] Background concentration in EPD’s
Tung Chung Air Quality Monitoring Station and Central Western Air Quality
Monitoring Station is not available.
[5] For predicted annual
average TAP concentration, “Yes” refers to its compliance with criteria and
“No” refers to its non-compliance with criteria.
[6] 1-hour concentration was converted
to 30-minute concentration by multiplying a factor of 1.41, based on Air
Dispersion Modeling Guideline for Ontario by Toronto
Ministry of the Environment.
Table17.2.34: Maximum incremental 1-hr / 24-hr average
TAP concentrations (µg/m3)
Major
Area |
Criteria |
Airport Island |
BCF |
Siu Ho Wan |
Sha Lo Wan |
San Shek Wan |
San Tau |
Sham Wat |
Tung Chung |
Tuen Mun |
1,3-butadiene
|
660[1] |
4.60E-01
(15.0%) |
1.98E-01
(7.6%) |
4.58E-01
(27.5%) |
1.12E+00
(49.2%) |
1.04E+00
(56.2%) |
8.25E-01
(32.1%) |
8.77E-01
(53.2%) |
1.16E+00
(56.9%) |
6.92E-01
(50.7%) |
Acetaldehyde
|
470[1] |
1.11E+00
(10.4%) |
4.90E-01
(6.0%) |
1.20E+00
(22.4%) |
2.95E+00
(42.4%) |
2.71E+00
(46.2%) |
2.17E+00
(27.8%) |
2.33E+00
(44.2%) |
3.01E+00
(47.6%) |
1.85E+00
(40.6%) |
Acrolein |
7[2] |
2.79E-01
(34.0%) |
2.28E-01
(34.6%) |
8.37E-02
(59.1%) |
1.97E-01
(50.5%) |
1.56E-01
(56.5%) |
7.57E-02
(10.4%) |
1.28E-01
(83.3%) |
9.87E-02
(37.0%) |
1.79E-01
(105.8%) |
Benzene |
29[2] |
2.22E-01
(7.6%) |
2.11E-02
(0.6%) |
1.05E-02
(0.4%) |
1.38E-01
(5.3%) |
9.41E-02
(3.8%) |
5.09E-02
(1.8%) |
8.14E-02
(3.4%) |
4.80E-02
(1.7%) |
1.43E-01
(6.1%) |
Ethylbenzene |
21700[2] |
2.08E-02
(0.4%) |
1.78E-02
(0.4%) |
6.57E-03
(0.1%) |
1.52E-02
(0.3%) |
1.38E-02
(0.3%) |
5.36E-03
(0.1%) |
9.90E-03
(0.2%) |
7.38E-03
(0.2%) |
1.46E-02
(0.3%) |
Formaldehyde
|
100[3] & [6] |
4.48E+00
(11.0%) |
1.97E+00
(6.6%) |
4.81E+00
(25.6%) |
1.20E+01
(47.3%) |
1.10E+01
(52.8%) |
8.86E+00
(30.9%) |
9.43E+00
(51.1%) |
1.22E+01
(53.8%) |
7.45E+00
(47.9%) |
Methyl
alcohol (Methanol) |
28000[1] |
5.59E-01
(25.5%) |
1.41E-01
(8.1%) |
4.34E-01
(48.9%) |
1.13E+00
(76.2%) |
1.05E+00
(97.0%) |
8.86E-01
(51.2%) |
8.78E-01
(101.0%) |
1.18E+00
(94.5%) |
6.70E-01
(102.0%) |
Xylene
(Total) |
8820[2] |
5.82E-02
(0.4%) |
5.10E-02
(0.4%) |
1.89E-02
(0.1%) |
4.59E-02
(0.4%) |
4.11E-02
(0.3%) |
1.43E-02
(0.1%) |
2.80E-02
(0.2%) |
2.09E-02
(0.2%) |
4.22E-02
(0.3%) |
Phenol
(carbolic acid) |
5800[1] |
2.25E-01
(25.5%) |
5.66E-02
(8.1%) |
1.75E-01
(48.9%) |
4.55E-01
(76.2%) |
4.23E-01
(97.0%) |
3.56E-01
(51.2%) |
3.53E-01
(101.0%) |
4.75E-01
(94.5%) |
2.70E-01
(102.0%) |
Styrene |
21630[2] |
3.28E-02
(2.4%) |
2.67E-02
(1.9%) |
9.83E-03
(0.7%) |
2.37E-02
(1.8%) |
1.91E-02
(1.4%) |
9.29E-03
(0.7%) |
1.54E-02
(1.2%) |
1.19E-02
(0.9%) |
2.14E-02
(1.6%) |
Toluene |
3750[2] |
1.04E-01
(0.7%) |
1.05E-01
(0.7%) |
3.64E-02
(0.2%) |
1.14E-01
(0.8%) |
8.94E-02
(0.6%) |
2.37E-02
(0.2%) |
5.45E-02
(0.4%) |
5.93E-02
(0.4%) |
7.94E-02
(0.5%) |
Arsenic |
0.2[1] |
4.84E-04
(2.2%) |
4.89E-05
(0.2%) |
5.66E-05
(0.3%) |
2.91E-04
(1.4%) |
2.13E-04
(1.0%) |
9.22E-05
(0.4%) |
2.02E-04
(1.0%) |
2.26E-04
(1.1%) |
2.20E-06
(0.0%) |
Cadmium |
0.03[2] |
5.63E-06
(0.1%) |
2.11E-06
(0.0%) |
9.33E-07
(0.0%) |
6.20E-08
(0.0%) |
4.69E-07
(0.0%) |
7.27E-08
(0.0%) |
2.35E-07
(0.0%) |
2.66E-06
(0.0%) |
1.03E-06
(0.0%) |
Chromium VI
|
0.3[2] |
-1.76E-04
(-2.0%) |
1.63E-05
(0.2%) |
5.45E-05
(0.7%) |
4.00E-04
(4.6%) |
3.78E-05
(0.4%) |
1.62E-04
(1.9%) |
1.20E-05
(0.1%) |
1.72E-04
(2.1%) |
1.37E-04
(1.6%) |
Copper |
100[1] |
-3.48E-03
(-1.3%) |
-3.35E-02
(-14.0%) |
4.96E-03
(3.3%) |
2.31E-02
(12.2%) |
-2.19E-03
(-1.3%) |
1.36E-03
(0.7%) |
-8.77E-03
(-5.0%) |
1.78E-02
(10.9%) |
5.98E-03
(3.7%) |
Nickel |
0.2[2] |
-2.04E-04
(-1.3%) |
3.72E-05
(0.2%) |
6.74E-05
(0.5%) |
4.82E-04
(3.2%) |
4.97E-05
(0.3%) |
1.94E-04
(1.3%) |
1.81E-05
(0.1%) |
2.12E-04
(1.5%) |
1.66E-04
(1.1%) |
Notes:
[1] Based on hourly average concentration.
[2] Based on daily average concentration.
[3] Based on 30-min average concentration.
[4] Incremental percentage change is listed in the ( ).
Carcinogenic
Health Risk
Table 17.2.35: Maximum incremental life
time carcinogenic health risk
Major Area |
Siu Ho Wan |
Sha Lo Wan |
San Shek Wan |
San Tau |
Sham Wat |
Tung Chung |
1,3-butadiene |
9.82E-08
(1.0%) |
3.67E-07
(3.1%) |
2.07E-07
(2.0%) |
1.49E-07
(1.4%) |
9.43E-08
(0.9%) |
1.05E-07
(1.0%) |
Acetaldehyde |
1.93E-08
(0.6%) |
6.97E-08
(1.9%) |
4.03E-08
(1.2%) |
2.83E-08
(0.8%) |
1.84E-08
(0.6%) |
2.06E-08
(0.6%) |
Benzene |
2.21E-08
(0.3%) |
7.96E-08
(0.9%) |
4.62E-08
(0.5%) |
3.41E-08
(0.4%) |
2.02E-08
(0.2%) |
2.88E-08
(0.3%) |
Benz(a)anthracene |
6.62E-12
(0.0%) |
4.39E-11
(0.1%) |
1.75E-11
(0.0%) |
5.40E-11
(0.1%) |
5.43E-12
(0.0%) |
3.48E-11
(0.1%) |
Benzo(a)pyrene |
7.13E-09
(0.0%) |
4.88E-08
(0.2%) |
1.96E-08
(0.1%) |
6.24E-08
(0.3%) |
5.85E-09
(0.0%) |
3.76E-08
(0.2%) |
Benzo(bk)fluoranthene |
1.72E-11
(0.0%) |
1.23E-10
(0.2%) |
4.53E-11
(0.1%) |
1.66E-10
(0.3%) |
1.24E-11
(0.0%) |
9.67E-11
(0.2%) |
Chrysene |
8.76E-13
(0.0%) |
5.49E-12
(0.1%) |
2.28E-12
(0.0%) |
6.71E-12
(0.1%) |
7.22E-13
(0.0%) |
4.56E-12
(0.1%) |
Dibenz(a,h)anthracene |
6.62E-12
(0.0%) |
1.07E-11
(0.0%) |
1.14E-11
(0.0%) |
3.39E-12
(0.0%) |
5.77E-12
(0.0%) |
6.82E-12
(0.0%) |
Ethylbenzene |
8.96E-10
(0.0%) |
3.73E-09
(0.1%) |
2.11E-09
(0.0%) |
1.52E-09
(0.0%) |
9.62E-10
(0.0%) |
9.40E-10
(0.0%) |
Formaldehyde |
3.27E-07
(0.7%) |
1.19E-06
(2.2%) |
6.85E-07
(1.4%) |
4.81E-07
(0.9%) |
3.12E-07
(0.7%) |
3.49E-07
(0.7%) |
Indeno(1,2,3-cd)pyrene |
5.14E-12
(0.0%) |
3.74E-11
(0.1%) |
1.35E-11
(0.0%) |
5.11E-11
(0.2%) |
3.63E-12
(0.0%) |
2.93E-11
(0.1%) |
Naphthalene |
4.12E-08
(0.2%) |
1.53E-07
(0.6%) |
8.55E-08
(0.3%) |
6.77E-08
(0.3%) |
3.88E-08
(0.1%) |
8.37E-08
(0.3%) |
Arsenic |
1.05E-09
(0.0%) |
7.57E-10
(0.0%) |
1.70E-09
(0.0%) |
1.13E-09
(0.0%) |
1.13E-09
(0.0%) |
1.05E-09
(0.0%) |
Beryllium |
1.46E-10
(0.2%) |
4.51E-10
(0.5%) |
2.96E-10
(0.3%) |
5.70E-10
(0.6%) |
1.29E-10
(0.1%) |
2.05E-10
(0.2%) |
Cadmium |
1.09E-10
(0.0%) |
3.38E-10
(0.0%) |
2.22E-10
(0.0%) |
4.28E-10
(0.0%) |
9.66E-11
(0.0%) |
1.53E-10
(0.0%) |
Chromium VI |
8.69E-08
(0.1%) |
1.09E-06
(1.0%) |
1.16E-07
(0.1%) |
3.20E-07
(0.3%) |
8.45E-08
(0.1%) |
1.75E-07
(0.2%) |
Diesel Particulate Matters |
2.21E-06
(0.3%) |
8.58E-06
(1.0%) |
4.90E-06
(0.6%) |
8.86E-06
(1.0%) |
1.80E-06
(0.2%) |
6.97E-06
(0.8%) |
Nickel |
1.03E-09
(0.1%) |
1.24E-08
(0.7%) |
1.37E-09
(0.1%) |
3.67E-09
(0.2%) |
1.00E-09
(0.1%) |
2.02E-09
(0.1%) |
Lead |
3.68E-11
(0.0%) |
4.33E-10
(0.1%) |
5.02E-11
(0.0%) |
1.31E-10
(0.0%) |
3.58E-11
(0.0%) |
7.12E-11
(0.0%) |
TCDD |
8.98E-10
(0.0%) |
3.66E-09
(0.1%) |
2.03E-09
(0.0%) |
3.80E-09
(0.0%) |
7.22E-10
(0.0%) |
3.09E-09
(0.0%) |
Total |
2.82E-06
(0.2%) |
1.14E-05
(0.6%) |
6.11E-06
(0.4%) |
9.99E-06
(0.6%) |
2.37E-06
(0.1%) |
7.65E-06
(0.4%) |
Note:
[1] Incremental percentage change is listed in
the ( ).
Criteria Pollutants
Short-Term Health Effects
Table 17.2.36: Incremental
change of maximum daily average concentrations of criteria pollutant at
different representative human receptors
Area |
HSR |
Incremental
(3RS - 2RS) Changes of Daily-avg. Conc. (µg/m3) |
|||
NO2 |
RSP |
FSP |
SO2 |
||
Tung Chung |
TC-1 |
-0.10 (-0.1%) |
-0.12
(-0.1%) |
0.00
(0.0%) |
0.20 (0.5%) |
TC-2 |
-0.08 (-0.1%) |
-0.17
(-0.1%) |
0.00
(0.0%) |
0.19 (0.5%) |
|
TC-3 |
-0.05 (-0.1%) |
-0.22
(-0.2%) |
0.00
(0.0%) |
0.19 (0.5%) |
|
TC-4 |
-0.05 (-0.1%) |
-0.23
(-0.2%) |
0.01
(0.0%) |
0.19 (0.5%) |
|
TC-5 |
-0.21 (-0.2%) |
-0.20
(-0.2%) |
-0.01
(0.0%) |
0.20 (0.5%) |
|
TC-6 |
-0.16 (-0.2%) |
-0.17
(-0.1%) |
-0.01
(0.0%) |
0.20 (0.5%) |
|
TC-7 |
-0.03 (0.0%) |
-0.22
(-0.2%) |
0.02
(0.0%) |
0.19 (0.5%) |
|
TC-8 |
-0.05 (-0.1%) |
0.23
(0.2%) |
0.11
(0.1%) |
0.01 (0.0%) |
|
TC-9 |
-0.06 (-0.1%) |
0.27
(0.2%) |
0.12
(0.1%) |
0.00 (0.0%) |
|
TC-10 |
-0.24 (-0.3%) |
0.31
(0.3%) |
0.11
(0.1%) |
0.01 (0.0%) |
|
TC-11 |
-0.20 (-0.2%) |
0.25
(0.2%) |
0.10
(0.1%) |
0.01 (0.0%) |
|
TC-12 |
-0.18 (-0.2%) |
0.17
(0.2%) |
0.09
(0.1%) |
0.01 (0.0%) |
|
TC-13 |
-0.09 (-0.1%) |
0.44
(0.4%) |
0.13
(0.1%) |
0.01 (0.0%) |
|
TC-14 |
-0.11 (-0.1%) |
0.39
(0.3%) |
0.13
(0.1%) |
0.01 (0.0%) |
|
TC-15 |
-0.10 (-0.1%) |
0.34
(0.3%) |
0.13
(0.1%) |
0.01 (0.0%) |
|
TC-16 |
-0.02 (0.0%) |
0.26
(0.2%) |
0.15
(0.2%) |
0.02 (0.0%) |
|
TC-17 |
0.10 (0.1%) |
0.24
(0.2%) |
0.14
(0.2%) |
0.01 (0.0%) |
|
TC-18 |
-0.17 (-0.2%) |
0.28
(0.2%) |
0.16
(0.2%) |
0.01 (0.0%) |
|
TC-19 |
-0.17 (-0.2%) |
-0.22
(-0.2%) |
0.02
(0.0%) |
0.19 (0.4%) |
|
TC-20 |
-0.30 (-0.3%) |
0.31
(0.3%) |
0.16
(0.2%) |
0.01 (0.0%) |
|
TC-21 |
0.34 (0.4%) |
0.15
(0.1%) |
0.14
(0.2%) |
-0.01 (0.0%) |
|
TC-22 |
0.52 (0.6%) |
0.18
(0.2%) |
0.14
(0.2%) |
-0.01 (0.0%) |
|
TC-23 |
0.81 (0.9%) |
-0.25
(-0.2%) |
0.03
(0.0%) |
0.25 (0.6%) |
|
TC-24 |
1.21 (1.4%) |
-0.21
(-0.2%) |
0.03
(0.0%) |
0.24 (0.6%) |
|
TC-25 |
1.20 (1.4%) |
-0.22
(-0.2%) |
0.03
(0.0%) |
0.24 (0.6%) |
|
TC-26 |
1.11 (1.3%) |
-0.22
(-0.2%) |
0.03
(0.0%) |
0.24 (0.6%) |
|
TC-27 |
1.26 (1.4%) |
-0.12
(-0.1%) |
0.02
(0.0%) |
0.23 (0.6%) |
|
TC-28 |
1.28 (1.5%) |
-0.17
(-0.2%) |
0.03
(0.0%) |
0.23 (0.6%) |
|
TC-29 |
1.16 (1.3%) |
-0.07
(-0.1%) |
0.02
(0.0%) |
0.24 (0.6%) |
|
TC-30 |
1.14 (1.3%) |
-0.02
(0.0%) |
0.01
(0.0%) |
0.24 (0.6%) |
|
TC-31 |
0.88 (1.0%) |
-0.15
(-0.1%) |
0.02
(0.0%) |
0.25 (0.6%) |
|
TC-32 |
0.35 (0.4%) |
-0.02
(0.0%) |
0.01
(0.0%) |
0.25 (0.6%) |
|
TC-33 |
0.05 (0.1%) |
-0.03
(0.0%) |
0.02
(0.0%) |
0.25 (0.6%) |
|
TC-34 |
0.37 (0.4%) |
-0.14
(-0.1%) |
0.02
(0.0%) |
0.26 (0.6%) |
|
TC-35 |
0.44 (0.5%) |
-0.23
(-0.2%) |
0.03
(0.0%) |
0.26 (0.6%) |
|
TC-36 |
0.35 (0.4%) |
-0.17
(-0.2%) |
0.03
(0.0%) |
0.26 (0.6%) |
|
TC-37 |
-0.16 (-0.2%) |
-0.02
(0.0%) |
0.02
(0.0%) |
0.26 (0.6%) |
|
TC-38 |
0.65 (0.8%) |
0.00
(0.0%) |
0.01
(0.0%) |
0.27 (0.7%) |
|
TC-39 |
0.74 (0.9%) |
0.01
(0.0%) |
0.01
(0.0%) |
0.25 (0.6%) |
|
TC-40 |
0.80 (0.9%) |
0.01
(0.0%) |
0.01
(0.0%) |
0.25 (0.6%) |
|
TC-41 |
0.75 (0.9%) |
-0.02
(0.0%) |
0.01
(0.0%) |
0.25 (0.6%) |
|
TC-42 |
0.78 (0.9%) |
-0.05
(0.0%) |
0.01
(0.0%) |
0.26 (0.6%) |
|
TC-43 |
0.73 (0.9%) |
-0.07
(-0.1%) |
0.01
(0.0%) |
0.26 (0.6%) |
|
TC-44 |
0.63 (0.8%) |
-0.08
(-0.1%) |
0.01
(0.0%) |
0.27 (0.7%) |
|
TC-45 |
0.55 (0.7%) |
-0.04
(0.0%) |
0.01
(0.0%) |
0.28 (0.7%) |
|
TC-46 |
0.91 (1.1%) |
0.01
(0.0%) |
0.01
(0.0%) |
0.23 (0.6%) |
|
TC-47 |
0.86 (1.0%) |
0.01
(0.0%) |
0.00
(0.0%) |
0.24 (0.6%) |
|
TC-48 |
0.75 (0.9%) |
-0.02
(0.0%) |
0.01
(0.0%) |
0.25 (0.6%) |
|
TC-49 |
0.72 (0.9%) |
-0.03
(0.0%) |
0.01
(0.0%) |
0.25 (0.6%) |
|
TC-50 |
0.61 (0.7%) |
-0.05
(0.0%) |
0.01
(0.0%) |
0.25 (0.6%) |
|
TC-51 |
0.45 (0.5%) |
-0.01
(0.0%) |
0.01
(0.0%) |
0.16 (0.4%) |
|
TC-52 |
-0.14 (-0.2%) |
0.03
(0.0%) |
0.01
(0.0%) |
0.00 (0.0%) |
|
TC-53 |
0.01 (0.0%) |
0.01
(0.0%) |
0.01
(0.0%) |
0.09 (0.2%) |
|
TC-54 |
0.58 (0.7%) |
-0.02
(0.0%) |
0.01
(0.0%) |
0.27 (0.7%) |
|
TC-55 |
-0.01 (0.0%) |
0.03
(0.0%) |
0.01
(0.0%) |
0.00 (0.0%) |
|
TC-56 |
-0.10 (-0.1%) |
0.03
(0.0%) |
0.01
(0.0%) |
0.00 (0.0%) |
|
TC-57 |
-0.04 (0.0%) |
0.02
(0.0%) |
0.01
(0.0%) |
0.00 (0.0%) |
|
TC-58 |
-0.08 (-0.1%) |
0.02
(0.0%) |
0.01
(0.0%) |
0.00 (0.0%) |
|
TC-59 |
-0.01 (0.0%) |
0.02
(0.0%) |
0.01
(0.0%) |
0.00 (0.0%) |
|
TC-P1 |
0.60 (0.7%) |
0.02
(0.0%) |
0.01
(0.0%) |
0.25 (0.6%) |
|
TC-P2 |
0.31 (0.3%) |
0.22
(0.2%) |
0.13
(0.2%) |
-0.02 (-0.1%) |
|
TC-P5 |
-0.12 (-0.1%) |
-0.07
(-0.1%) |
0.02
(0.0%) |
0.10 (0.2%) |
|
TC-P6 |
0.25 (0.3%) |
-0.02
(0.0%) |
0.02
(0.0%) |
0.30 (0.7%) |
|
TC-P7 |
0.37 (0.4%) |
0.33
(0.3%) |
0.13
(0.1%) |
0.01 (0.0%) |
|
TC-P8 |
-0.23 (-0.3%) |
-0.24
(-0.2%) |
0.00
(0.0%) |
0.23 (0.6%) |
|
TC-P9 |
1.21 (1.3%) |
0.09
(0.1%) |
0.06
(0.1%) |
0.27 (0.7%) |
|
TC-P10 |
1.49 (1.5%) |
0.37
(0.3%) |
0.08
(0.1%) |
1.54 (3.4%) |
|
TC-P11 |
2.85 (3.0%) |
0.32
(0.3%) |
0.09
(0.1%) |
1.31 (2.9%) |
|
TC-P12 |
-0.14 (-0.2%) |
-0.15
(-0.1%) |
0.06
(0.1%) |
0.03 (0.1%) |
|
TC-P13 |
-0.54 (-0.6%) |
-0.30
(-0.3%) |
-0.01
(0.0%) |
0.22 (0.5%) |
|
TC-P14 |
-0.26 (-0.3%) |
-0.20
(-0.2%) |
-0.01
(0.0%) |
0.20 (0.5%) |
|
TC-P15 |
-0.64 (-0.7%) |
-0.11
(-0.1%) |
0.00
(0.0%) |
0.21 (0.5%) |
|
TC-P16 |
0.41 (0.4%) |
-0.06
(-0.1%) |
0.00
(0.0%) |
0.22 (0.5%) |
|
TC-P17 |
0.58 (0.7%) |
-0.02
(0.0%) |
0.01
(0.0%) |
0.26 (0.6%) |
|
San Tau |
ST-1 |
-1.61 (-1.7%) |
0.03
(0.0%) |
0.01
(0.0%) |
0.02 (0.1%) |
ST-2 |
-1.36 (-1.4%) |
0.03
(0.0%) |
0.01
(0.0%) |
0.02 (0.0%) |
|
ST-3 |
-1.17 (-1.3%) |
0.02
(0.0%) |
0.01
(0.0%) |
0.03 (0.1%) |
|
Sha Lo Wan |
SLW-1 |
-12.08
(-9.9%) |
-0.11
(-0.1%) |
-0.01
(0.0%) |
1.07 (2.3%) |
SLW-2 |
-11.63
(-10.2%) |
0.01
(0.0%) |
0.00
(0.0%) |
0.64 (1.4%) |
|
SLW-3 |
-2.59 (-2.3%) |
-0.34
(-0.3%) |
-0.03
(0.0%) |
0.19 (0.4%) |
|
SLW-4 |
-1.12 (-1.0%) |
-0.41
(-0.4%) |
-0.04
(0.0%) |
0.17 (0.4%) |
|
San Shek Wan |
SSW-1 |
2.10 (2.2%) |
-0.17
(-0.2%) |
-0.01
(0.0%) |
0.09 (0.2%) |
Sham Wat |
SW-1 |
0.22 (0.3%) |
0.00
(0.0%) |
0.00
(0.0%) |
0.04 (0.1%) |
SW-2 |
0.99 (1.1%) |
0.01
(0.0%) |
0.00
(0.0%) |
0.93 (1.8%) |
|
Siu Ho Wan |
SHW-1 |
0.19 (0.2%) |
0.22
(0.2%) |
0.10
(0.1%) |
0.00 (0.0%) |
SHW-2 |
-0.27 (-0.3%) |
-0.03
(0.0%) |
0.01
(0.0%) |
-0.20 (-0.5%) |
|
SHW-3 |
3.72 (4.2%) |
0.11
(0.1%) |
0.06
(0.1%) |
2.76 (6.4%) |
|
SHW-4 |
2.65 (2.9%) |
0.13
(0.1%) |
0.06
(0.1%) |
0.17 (0.4%) |
|
SHW-5 |
-0.38 (-0.4%) |
-0.02
(0.0%) |
0.00
(0.0%) |
-0.22 (-0.5%) |
|
Proposed Lantau
Logistic Park |
LLP-P1 |
3.13 (3.5%) |
0.14
(0.1%) |
0.06
(0.1%) |
0.11 (0.3%) |
LLP-P2 |
-0.95 (-1.0%) |
0.11
(0.1%) |
0.04
(0.0%) |
-0.71 (-1.5%) |
|
LLP-P3 |
-2.52 (-2.7%) |
0.13
(0.1%) |
0.04
(0.0%) |
-0.92 (-2.0%) |
|
LLP-P4 |
-1.22 (-1.3%) |
0.07
(0.1%) |
0.03
(0.0%) |
-0.62 (-1.3%) |
|
Tuen Mun |
TM-7 |
0.08 (0.1%) |
-0.03
(0.0%) |
0.09
(0.1%) |
0.01 (0.0%) |
TM-8 |
0.07 (0.1%) |
-0.07
(-0.1%) |
0.13
(0.1%) |
0.03 (0.1%) |
|
TM-9 |
0.10 (0.1%) |
-0.04
(0.0%) |
0.13
(0.1%) |
0.03 (0.1%) |
|
TM-10 |
0.08 (0.1%) |
-0.26
(-0.2%) |
0.17
(0.2%) |
0.03 (0.1%) |
|
TM-11 |
-0.02 (0.0%) |
-0.05
(0.0%) |
0.11
(0.1%) |
-0.02 (0.0%) |
|
TM-12 |
0.05 (0.1%) |
0.11
(0.1%) |
0.11
(0.1%) |
0.03 (0.1%) |
|
TM-13 |
-0.09 (-0.1%) |
0.11
(0.1%) |
0.09
(0.1%) |
0.10 (0.2%) |
|
TM-14 |
0.35 (0.4%) |
0.05
(0.0%) |
0.06
(0.1%) |
-0.05 (-0.1%) |
|
TM-15 |
-0.18 (-0.2%) |
0.06
(0.1%) |
0.06
(0.1%) |
-0.05 (-0.1%) |
|
TM-16 |
0.06 (0.1%) |
-0.22
(-0.2%) |
0.15
(0.2%) |
0.03 (0.1%) |
|
TM-17 |
0.06 (0.1%) |
0.03
(0.0%) |
0.11
(0.1%) |
0.02 (0.0%) |
|
TM-18 |
0.05 (0.0%) |
0.02
(0.0%) |
0.10
(0.1%) |
0.02 (0.0%) |
|
TM-19 |
-0.02 (0.0%) |
0.03
(0.0%) |
0.10
(0.1%) |
-0.02 (0.0%) |
|
Airport |
AI-C1 |
16.39 (14.4%) |
-2.55
(-2.0%) |
0.12
(0.1%) |
11.12 (19.5%) |
AI-C2 |
5.79 (5.7%) |
-2.38
(-1.9%) |
-0.05
(-0.1%) |
3.92 (7.6%) |
|
AI-C3 |
6.06 (5.9%) |
-1.67
(-1.3%) |
0.03
(0.0%) |
4.21 (8.1%) |
|
AI-C4 |
7.20 (6.8%) |
-0.32
(-0.3%) |
0.14
(0.2%) |
5.31 (10.1%) |
|
AI-C5 |
10.97 (10.0%) |
-0.31
(-0.2%) |
0.20
(0.2%) |
7.57 (13.9%) |
|
AI-C6 |
11.58 (10.4%) |
0.22
(0.2%) |
0.21
(0.2%) |
7.71 (14.1%) |
|
Hong Kong Boundary Crossing Facilities |
BCF-1 |
6.80 (6.5%) |
0.28
(0.2%) |
-0.01
(0.0%) |
7.12 (13.0%) |
Notes:
[1]
Values in ( ) indicate the percentage
change with reference to 2RS.
[2]
Incremental change of max. daily-avg. conc. = max. daily conc. of 3RS – max. daily
conc. of 2RS.
Table 17.2.37: Incremental unit risk of hospital
admission per annum attributable to NO2, RSP and SO2
Major Area |
Incremental
Unit Risk per Annum of Hospital Admission [2] & [3] |
Incremental
Unit Risk per Annum of Hospital Admission [2] & [4] |
||
Cardiovascular
Disease |
Respiratory
Disease |
Cardiovascular
Disease |
Respiratory
Disease |
|
Tung Chung |
8.20E-06 |
5.75E-06 |
2.93E-05 |
1.71E-05 |
(5.69E-06 –
1.06E-05) |
(3.28E-06 –
8.21E-06) |
(1.94E-05 –
3.84E-05) |
(7.66E-06 –
2.65E-05) |
|
San Tau |
1.15E-05 |
7.45E-06 |
-2.89E-05 |
-2.39E-05 |
(7.66E-06 –
1.51E-05) |
(3.73E-06 –
1.11E-05) |
(-3.62E-05 –
-2.13E-05) |
(-3.16E-05 –
-1.61E-05) |
|
Sha Lo Wan |
-4.17E-05 |
-3.36E-05 |
-2.07E-04 |
-1.80E-04 |
(-5.22E-05 –
-3.08E-05) |
(-4.47E-05 –
-2.26E-05) |
(-2.58E-04 –
-1.54E-04) |
(-2.34E-04 –
-1.26E-04) |
|
San Shek Wan |
-1.86E-05 |
-1.62E-05 |
-1.18E-05 |
-1.30E-05 |
(-2.30E-05 –
-1.41E-05) |
(-2.09E-05 –
-1.15E-05) |
(-1.49E-05 –
-8.83E-06) |
(-1.61E-05 –
-9.80E-06) |
|
Sham Wat |
7.59E-06 |
5.10E-06 |
3.16E-05 |
1.60E-05 |
(5.00E-06 –
1.00E-05) |
(2.60E-06 –
7.60E-06) |
(2.03E-05 –
4.20E-05) |
(5.33E-06 –
2.66E-05) |
|
Siu Ho Wan |
6.31E-06 |
4.53E-06 |
7.62E-06 |
6.88E-06 |
(4.41E-06 –
8.11E-06) |
(2.65E-06 –
6.39E-06) |
(5.22E-06 –
9.95E-06) |
(4.49E-06 –
9.27E-06) |
|
Airport |
4.65E-05 |
2.68E-05 |
4.52E-04 |
2.34E-04 |
(3.17E-05 –
6.02E-05) |
(1.25E-05 –
4.10E-05) |
(2.97E-04 –
5.95E-04) |
(8.67E-05 –
3.81E-04) |
[3] With
reference to incremental change of annual-avg. concentration for averaged daily
concentration determination.
[4] With reference to incremental change of max. daily-avg. concentration.
[5] The
incremental unit risks are estimated with references to the average values of
RR. The values in the brackets indicate the 95% confidence intervals of RR.
Table 17.2.38: Incremental unit risk of premature deaths
(short-term mortality) due to all-causes per annum attributable to NO2, RSP and SO2
Major
Area |
Incremental Unit Risk per Annum of All-cause Premature Deaths (Short-Term Mortality) [2] & [3] |
Incremental Unit Risk per Annum of All-cause Premature Deaths (Short-Term Mortality) [2] & [4] |
Tung Chung |
2.23E-06 |
7.86E-06 |
San Tau |
3.07E-06 |
-8.07E-06 |
Sha Lo Wan |
-1.17E-05 |
-5.81E-05 |
San Shek Wan |
-5.27E-06 |
-3.23E-06 |
Sham Wat |
2.00E-06 |
8.39E-06 |
Siu Ho Wan |
1.73E-06 |
2.00E-06 |
Airport |
1.27E-05 |
1.22E-04 |
Long Term
Health Effect
Table 17.2.39: Incremental annual average concentrations of criteria pollutant at different representative human receptors
Area |
HSR |
Incremental
(3RS - 2RS) Changes of Annual-avg.
Conc. (µg/m3) |
|||
NO2 |
RSP |
FSP |
SO2 |
||
Tung Chung |
TC-1 |
0.34 (1.2%) |
0.03 (0.1%) |
0.02 (0.1%) |
0.07 (1.1%) |
TC-2 |
0.36 (1.3%) |
0.04 (0.1%) |
0.02 (0.1%) |
0.06 (1.1%) |
|
TC-3 |
0.34 (1.2%) |
0.04 (0.1%) |
0.02 (0.1%) |
0.07 (1.1%) |
|
TC-4 |
0.32 (1.1%) |
0.04 (0.1%) |
0.02 (0.1%) |
0.07 (1.1%) |
|
TC-5 |
0.27 (1.0%) |
0.04
(0.1%) |
0.02
(0.1%) |
0.07 (1.1%) |
|
TC-6 |
0.27 (1.0%) |
0.04
(0.1%) |
0.02
(0.1%) |
0.07 (1.1%) |
|
TC-7 |
0.32 (1.1%) |
0.04 (0.1%) |
0.02 (0.1%) |
0.07 (1.1%) |
|
TC-8 |
0.38 (1.4%) |
0.05 (0.1%) |
0.02 (0.1%) |
0.08 (1.4%) |
|
TC-9 |
0.38 (1.3%) |
0.05 (0.1%) |
0.02 (0.1%) |
0.08 (1.4%) |
|
TC-10 |
0.30 (1.1%) |
0.04 (0.1%) |
0.02 (0.1%) |
0.08 (1.4%) |
|
TC-11 |
0.31 (1.1%) |
0.04 (0.1%) |
0.02 (0.1%) |
0.08 (1.4%) |
|
TC-12 |
0.31 (1.1%) |
0.04 (0.1%) |
0.02 (0.1%) |
0.09 (1.4%) |
|
TC-13 |
0.33 (1.2%) |
0.05 (0.1%) |
0.03 (0.1%) |
0.09 (1.4%) |
|
TC-14 |
0.34 (1.2%) |
0.05 (0.1%) |
0.03 (0.1%) |
0.08 (1.4%) |
|
TC-15 |
0.35 (1.2%) |
0.05 (0.1%) |
0.02 (0.1%) |
0.08 (1.4%) |
|
TC-16 |
0.58 (1.9%) |
0.06
(0.1%) |
0.04
(0.1%) |
0.09 (1.4%) |
|
TC-17 |
0.55 (1.8%) |
0.05
(0.1%) |
0.03
(0.1%) |
0.08 (1.4%) |
|
TC-25 |
0.36 (1.4%) |
0.03
(0.1%) |
0.02
(0.1%) |
0.05 (0.9%) |
|
TC-26 |
0.34 (1.3%) |
0.03
(0.1%) |
0.02
(0.1%) |
0.05 (0.9%) |
|
TC-27 |
0.29 (1.1%) |
0.02
(0.1%) |
0.02 (0.1%) |
0.05 (0.9%) |
|
TC-28 |
0.30 (1.2%) |
0.02
(0.1%) |
0.02
(0.1%) |
0.05 (0.9%) |
|
TC-29 |
0.28 (1.1%) |
0.02 (0.1%) |
0.02 (0.1%) |
0.05 (0.9%) |
|
TC-30 |
0.27 (1.1%) |
0.02 (0.1%) |
0.01 (0.1%) |
0.05 (0.8%) |
|
TC-31 |
0.30 (1.2%) |
0.03 (0.1%) |
0.02 (0.1%) |
0.05 (0.9%) |
|
TC-32 |
0.25 (0.9%) |
0.02 (0.1%) |
0.02 (0.1%) |
0.05 (0.9%) |
|
TC-33 |
0.26 (0.9%) |
0.02 (0.1%) |
0.02 (0.1%) |
0.05 (0.9%) |
|
TC-34 |
0.28 (1.1%) |
0.02 (0.1%) |
0.02 (0.1%) |
0.05 (0.9%) |
|
TC-35 |
0.29 (1.1%) |
0.03 (0.1%) |
0.02 (0.1%) |
0.05 (0.9%) |
|
TC-36 |
0.25 (0.9%) |
0.02 (0.1%) |
0.02 (0.1%) |
0.05 (0.9%) |
|
TC-37 |
0.21 (0.7%) |
0.01 (0.0%) |
0.02 (0.1%) |
0.05 (0.9%) |
|
TC-38 |
0.23 (1.0%) |
0.00 (0.0%) |
0.01 (0.1%) |
0.05 (0.8%) |
|
TC-39 |
0.24 (0.9%) |
0.00 (0.0%) |
0.01 (0.0%) |
0.04 (0.8%) |
|
TC-40 |
0.24 (1.0%) |
0.00 (0.0%) |
0.01 (0.0%) |
0.04 (0.8%) |
|
TC-41 |
0.25 (1.0%) |
0.00 (0.0%) |
0.01 (0.0%) |
0.04 (0.8%) |
|
TC-42 |
0.25 (1.0%) |
0.00 (0.0%) |
0.01 (0.0%) |
0.05 (0.8%) |
|
TC-43 |
0.25 (1.1%) |
0.00 (0.0%) |
0.01 (0.0%) |
0.05 (0.8%) |
|
TC-44 |
0.24 (1.0%) |
0.00 (0.0%) |
0.01 (0.0%) |
0.05 (0.8%) |
|
TC-45 |
0.21 (0.9%) |
-0.01 (0.0%) |
0.02 (0.1%) |
0.05 (0.9%) |
|
TC-46 |
0.23 (1.0%) |
0.00
(0.0%) |
0.01
(0.0%) |
0.04 (0.7%) |
|
TC-47 |
0.23 (1.0%) |
0.00
(0.0%) |
0.01
(0.0%) |
0.04 (0.7%) |
|
TC-48 |
0.24 (1.0%) |
0.01
(0.0%) |
0.01
(0.0%) |
0.04 (0.8%) |
|
TC-49 |
0.24 (1.1%) |
0.01
(0.0%) |
0.01
(0.0%) |
0.04 (0.8%) |
|
TC-50 |
0.24 (1.0%) |
0.00
(0.0%) |
0.01 (0.0%) |
0.04 (0.8%) |
|
TC-51 |
0.24 (1.1%) |
0.01
(0.0%) |
0.01
(0.0%) |
0.05 (0.8%) |
|
TC-52 |
0.40 (1.5%) |
0.02
(0.1%) |
0.02
(0.1%) |
0.09 (1.6%) |
|
TC-53 |
0.32 (1.2%) |
0.02
(0.0%) |
0.01
(0.1%) |
0.07 (1.2%) |
|
TC-54 |
0.24 (1.0%) |
0.00 (0.0%) |
0.01
(0.0%) |
0.05 (0.9%) |
|
TC-55 |
0.43 (1.7%) |
0.04
(0.1%) |
0.02
(0.1%) |
0.11 (1.9%) |
|
TC-56 |
0.40 (1.6%) |
0.03
(0.1%) |
0.01
(0.1%) |
0.09 (1.6%) |
|
TC-57 |
0.39 (1.6%) |
0.03
(0.1%) |
0.01
(0.1%) |
0.09 (1.6%) |
|
TC-58 |
0.38 (1.5%) |
0.02
(0.1%) |
0.01
(0.0%) |
0.08 (1.4%) |
|
TC-59 |
0.37 (1.5%) |
0.02
(0.1%) |
0.01
(0.0%) |
0.08 (1.4%) |
|
TC-P1 |
0.23 (0.9%) |
0.00
(0.0%) |
0.01
(0.0%) |
0.05 (0.8%) |
|
TC-P5 |
0.31 (1.1%) |
0.01 (0.0%) |
0.02 (0.1%) |
0.08 (1.3%) |
|
TC-P6 |
0.15 (0.6%) |
-0.05 (-0.1%) |
0.03 (0.1%) |
0.05 (0.8%) |
|
TC-P7 |
0.20 (0.7%) |
0.02 (0.1%) |
0.03 (0.1%) |
0.08 (1.3%) |
|
TC-P8 |
0.25 (1.0%) |
0.03 (0.1%) |
0.02 (0.1%) |
0.07 (1.2%) |
|
TC-P9 |
0.31 (1.3%) |
0.01 (0.0%) |
0.01 (0.0%) |
0.08 (1.3%) |
|
TC-P10 |
0.39 (1.5%) |
0.02 (0.1%) |
0.02 (0.1%) |
0.11 (1.9%) |
|
TC-P11 |
0.38 (1.4%) |
0.04 (0.1%) |
0.02 (0.1%) |
0.11 (1.9%) |
|
TC-P13 |
0.12 (0.4%) |
0.04
(0.1%) |
0.02
(0.1%) |
0.07 (1.2%) |
|
TC-P14 |
0.26 (1.0%) |
0.04
(0.1%) |
0.02
(0.1%) |
0.07 (1.1%) |
|
TC-P15 |
-0.04 (-0.1%) |
0.03
(0.1%) |
0.02
(0.1%) |
0.07 (1.1%) |
|
TC-P16 |
0.36 (1.3%) |
0.02
(0.1%) |
0.02
(0.1%) |
0.06 (1.1%) |
|
TC-P17 |
0.25 (1.1%) |
0.01
(0.0%) |
0.01
(0.0%) |
0.05 (0.8%) |
|
San Tau |
ST-1 |
0.33 (1.1%) |
0.09 (0.2%) |
0.03 (0.1%) |
0.16 (2.5%) |
ST-2 |
0.28 (0.9%) |
0.08 (0.2%) |
0.02 (0.1%) |
0.17 (2.6%) |
|
ST-3 |
0.38 (1.3%) |
0.08 (0.2%) |
0.02 (0.1%) |
0.15 (2.3%) |
|
Sha Lo Wan |
SLW-1 |
-2.65 (-6.9%) |
0.22 (0.5%) |
0.03 (0.1%) |
-0.04 (-0.5%) |
SLW-2 |
-1.76 (-5.1%) |
0.17 (0.4%) |
0.03 (0.1%) |
0.04 (0.5%) |
|
SLW-3 |
-1.30 (-4.1%) |
0.09 (0.2%) |
0.02 (0.1%) |
0.06 (0.8%) |
|
SLW-4 |
-1.45 (-4.5%) |
0.10
(0.2%) |
0.02
(0.1%) |
0.05 (0.6%) |
|
San Shek Wan |
SSW-1 |
-0.26 (-1.0%) |
0.05 (0.1%) |
0.02 (0.1%) |
0.16 (2.3%) |
Sham Wat |
SW-1 |
0.13 (0.6%) |
0.03 (0.1%) |
0.01 (0.0%) |
0.11 (1.8%) |
SW-2 |
0.21 (1.0%) |
0.13
(0.3%) |
0.01
(0.0%) |
0.10 (1.6%) |
|
Siu Ho Wan |
SHW-1 |
0.24 (1.0%) |
0.01 (0.0%) |
0.01 (0.0%) |
0.05 (0.8%) |
SHW-2 |
0.24 (1.0%) |
0.02 (0.0%) |
0.01 (0.0%) |
0.06 (1.0%) |
|
SHW-3 |
0.25 (1.1%) |
0.03 (0.1%) |
0.01 (0.0%) |
0.10 (1.8%) |
|
SHW-5 |
0.22 (0.9%) |
0.02
(0.0%) |
0.01
(0.0%) |
0.05 (0.9%) |
Note:
[1]
Values in ( ) indicate the percentage
change with reference to 2RS.
Table 17.2.40: Incremental unit risk of premature
deaths (long-term mortality) due to all-causes
per annum attributable to FSP
Major Area |
Incremental Unit Risk of All-cause
Premature Deaths per Annum (Long-Term Mortality) [1] |
Tung Chung |
3.99E-07 (1.03E-07 - 7.68E-07) |
San Tau |
5.65E-07 (1.45E-07 - 1.09E-06) |
Sha Lo Wan |
6.61E-07 (1.70E-07 - 1.27E-06) |
San Shek Wan |
5.20E-07 (1.34E-07 - 1.00E-06) |
Sham Wat |
2.94E-07 (7.56E-08 - 5.66E-07) |
Siu Ho Wan |
2.26E-07 (5.83E-08 - 4.36E-07) |
ˇ Banned all idling vehicle engines on the airside since 2008, except for certain vehicles that are exempted;
ˇ Banning the use of APU for all aircraft at frontal stands by end 2014;
ˇ Requiring all saloon vehicles as electric vehicles by end 2017;
ˇ Increasing charging stations for electric vehicles and electric GSE to a total of 290 by end 2018;
ˇ Conducting review on existing GSE emission performance and explore measures to further control air emissions;
ˇ Exploring with franchisees feasibility of expediting replacement of old airside vehicles and GSE with cleaner ones during tender or renewal of contracts;
ˇ Requiring all new airside vehicles to be fuel-efficient and making it a prerequisite for the licensing process;
ˇ Providing the cleanest diesel and gasoline at the airfield;
ˇ Requiring all of the AAHK’s diesel vehicles to use biodiesel (B5);
ˇ Promoting increased use of electric vehicles and electric ground service equipment at HKIA by provision of charging infrastructure; and
ˇ
Providing a liquefied
petroleum gas (LPG) fuelling point for airside vehicles and ground service
equipment.
ˇ The Year 2011 monitoring data has been adopted as background for TAP. This cannot reflect the improvement in air quality due to implementation of short-term and long-term control measures by the Government. This may overestimate the associated health risks;
ˇ The modeling verification suggests that the model results will over-estimate the predicted pollutant concentrations, which in turn will overestimate the health risks. Hence, it is considered that the assessments of the health impact would be conservative;
ˇ In determining the total risks of hospital admissions and mortalities, the hospital admissions and mortalities risk associated with each individual criteria pollutant are summed. The RR for short-term health effects (both hospital admissions and deaths) of each criteria pollutant was derived from a single-pollutant statistical model. Therefore, the estimates of the effect of one pollutant will include the effects of another, if the two pollutants are correlated. This is especially true for NO2 and PM according to WHO. Hence, there will be overlaps in the estimation of hospital admissions and deaths by adding up the effects of all the criteria pollutants, resulting in an overestimation of health risks; and
ˇ The toxicity criteria adopted from agencies (WHO, IRIS, etc.) would
introduce uncertainty to the risk assessment. These toxicity criteria are used
as single-point estimates throughout the analysis with uncertainty and
variability associated with them. The
application of safety factor to LOAEL or NOAEL for derivation of toxicity
criteria for long-term chronic toxicity is another source of uncertainty. This uncertainty may overestimate or
underestimate the risk.
Objectives
Literature Review Process
Key
Findings of Literature Review
ˇ Good Practice Guide on Noise Exposure and Potential Health Effects. EEA Technical Report No. 11/2010, October 2010.
ˇ World Health Organization, 2012. Methodological Guidance for Estimating the Burden of Disease from Environmental Noise. Copenhagen, WHO Regional Office for Europe.
Definition of Health
End Points
Selection of Noise
Metrics
ˇ Lden: This is the day-evening-night noise level. It is a descriptor of noise level based on energy equivalent noise level (Leq) over a whole day with a penalty of 10 dB(A) for night time noise (2300 to 0700) and a penalty of 5 dB(A) for evening noise (1900 to 2300).
ˇ Lnight: This is the equivalent continuous noise level over the night-time period (2300 to 0700), which does not contain any night-time noise weighting.
ˇ LAeq, 16hr: This is the equivalent sound level (often called equivalent continuous sound level) averaged over 16 hours (0700 to 2300).
Prediction of HIA
Noise Metrics
Assessment Area
Areas |
Approx. NEF Range based on INM Modeling Results in Year 2030 |
1. Ma Wan |
< 25 |
2. Tuen Mun |
<< 25 |
3. Tsing Lung Tau |
<< 25 |
4. Shatin |
<< 25 |
5. Ma On Shan |
<< 25 |
6. Tsuen Wan |
<< 25 |
7. Sham Tseng |
<< 25 |
8. Tsing Yi |
<< 25 |
9. Tung Chung |
< 25 |
10. Tai Kok
Tsui |
<< 25 |
11. Siu Lam
|
< 25 (except a portion in Lok On Pai) |
12. Yuen Long |
<< 25 |
13. Kwai
Chung |
<< 25 |
14. Sha Lo Wan |
25 to 30 |
15. North Lantau
Villages |
25 to 30 |
Remarks: Bolded areas are identified as locations of interest (hereafter
collectively referred to as assessment area) for a quantitative comparison of
the 3RS and 2RS scenarios in the HIA.
Other areas are subject to aircraft noise levels
substantially below
the EIAO-TM criterion of NEF25 (i.e. << 25).
Annoyance
Predicted Noise Levels, Lden (dB) |
Estimated Change in Population that might be Highly Annoyed, 3RS - 2RS |
45 – 50 |
-600 |
50 – 55 |
7,800 |
55 – 60 |
-10,700 |
60 – 65 |
-200 |
65 – 70 |
0 |
70 – 75 |
0 |
Overall Change in Population |
-3,700 |
Overall % Change in Population |
-9.6% |
Self-reported Sleep
Disturbance
Predicted Noise Levels, Lnight (dB) |
Estimated Change in Population who might be Highly Sleep Disturbed, 3RS - 2RS |
45 – 50 |
-900 |
50 – 55 |
-8,100 |
55 – 60 |
0 |
60 – 65 |
0 |
65 – 70 |
0 |
70 – 75 |
0 |
Overall Change in Population |
-9,000 |
Overall % Change in Population |
-47.8% |
Other Potential
Noise Effects
ˇ Putting the existing south runway on standby where possible at night between 2300 and 0659;
ˇ Requiring departures to take the southbound route via West Lamma Channel during east flow at night from 2300 to 0659, subject to acceptable operational and safety consideration. This is an arrangement that is consistent with the existing requirement in the operation of the two-runway system at night;
ˇ A new arrival Required Navigation Performance (RNP) Track 6 has been designed for preferential use in the west flow direction (i.e., runway 25 direction) between 2300 and 0659 and it is assumed that up to 95% of flights may preferentially use this new Track 6 instead of the existing straight-in tracks by year 2030; and
ˇ Implementing a preferential runway use programme when wind conditions allow such that west flow is used when departures dominate while east flow is used when arrivals dominate during night-time.
Aircraft and
Airport-Related Hazardous Air Pollutants: Research Needs and Analysis, ACRP,
2008.
A Method to Estimate the Chronic Health Impact of Air Pollutants in .US. Residences, Ernest Orlando Lawrence Berkeley National
Laboratory, 2011.
Air Pollution and
Health: A European Information System (APHEIS), Health Impact Assessment of Air
Pollution and Communication Strategy.
Airport
Cooperative Research Program Report 7: Aircraft and Airport-Related Hazardous
Air Pollutants: Research Needs and Analysis, Transport Research Board, 2008.
Air Quality
Manual, ICAO, 2011.
Agreement No. CE 29/2008 (EP) Engineering
Investigation and Environmental Studies for Integrated Waste Management
Facilities Phase 1 – Feasibility Study, EPD, 2011.
Agreement No CE
57/2006 (EP) Review of Air Quality Objectives and Development of a Long Term
Air Quality Strategy for Hong Kong - Feasibility Study, ARUP/EPD, 2009.
APHES: Health Impact Assessment of Air Pollution
and Communication Strategy. Third Year Report. ISBN: 2-11-094838-8; Institut
de Veille Sanitaire; June 2005. Downloaded from: http://www.apheis.org/vfbisnvsApheis.pdf]
Assessment of Toxic Air Pollutant Measurements in Hong Kong, EPD, 2003.
CAFÉ Program
Methodology for the Cost-Benefit analysis for CAFE: Volume 2: Health Impact
Assessment, AEA
Technology Environment / European Commission DG Environment, 2005.
EIA report for development of the Integrated Waste Management Facilities
Phase 1, EPD, 2011.
EIS / MDP for the
New Parallel Runway (NPR) of Brisbane Airport Volume D7 Health Impact
Assessment, 2007:
http://www.bne.com.au/corporate/major-projects/new-parallel-runway-project/eismdp
Environmental Impact Statement for Fort Lauderdale – Hollywood
International Airport, FAA, 2008.
Evaluation and use of epidemiological evidence for environmental health
risk assessment, WHO, 2000.
General Aviation
Airport Air Monitoring Study, USEPA , 2010.
Health Impact Assessment for Finningley
Airport, Doncaster Health Authority, 2005.
Health Impact Assessment for Schiphol Airport, National Institute of
Public Health, Bilthoven, 1994.
Hospital
statistical Yearbook 2011 – 2012, Hospital Authority Hong Kong
High-Priority
Compounds Associated with Aircraft Emissions PARTNER Project 11 final
report on subtask: Health Risk Prioritization of Aircraft Emissions Related Air
Pollutants, Partnership for AiR Transportation Noise
and Emissions Reduction An FAA/NASA/Transport Canada sponsored Center of Excellence, 2008.
Human Health Risk
Assessment Technical Report for LAX Master Plan EIS / EIR, Camp Dresser & Mckee Inc., 2001
Human Health risk
Assessment of air emissions from proposed biosolids
incinerator, The City of Hamilton, US, 2010.
Huijbregts, MAJ, Rombouts, LJA,
Ragas, AMJ, van de Meent, D. 2005.
Human-toxicological effect and damage factors of carcinogenic and noncarcinogenic chemicals for life cycle impact assessment.
Integrated Environmental Assessment and Management 1(3): 181-244.
McDonnell WF et al. Relationships of mortality with
the fine and coarse fractions of long-term ambient PM10 concentrations in nonsmokers. Journal of Exposure Analysis and Environmental
Epidemiology 2000;10:427-436;
O'Hare Modernization Final Environmental Impact Statement, Chicago
O’Hare International Airport, 2005.
Pope, A.C., et al., Lung Cancer, Cardiopulmonary Mortality, and
Long-term Exposure to Fine Particulate Air Pollution, Journal of the American
Medical Association, 2002.
Santa Monica
Airport Health Impact Assessment (HIA), UCLA, 2010.
Select Resource Materials
and Annotated Bibliograpjy on the Topic of Hazardous
Air Pollutants (HAPs) Associated with Aircraft, Airport, and Aviation, FAA,
2003.
Source
Identification and Base Year 1990 Emission Inventory Guidance for Mobile
Sources HAPs on the OAQPS List of 40 Priority HAPs, USEPA, 1997.
The Stansted
Generation 2 Project – A health Impact Assessment, ERM, 2008.
Health Impact
Assessment Schiphol Airport, The National Institute of
Public Health and Environmental Protection (RIVM), 1994.
Health Assessment
Document For Diesel Engine Exhaust, USEPA, 2002
USEPA’s Air Toxics
Risk Assessment Reference Library - Volume 2 Facility-Specific Assessment
(EPA-453-K-04-001B), 2004.
Wong, C.M.,
McGhee, S.M., Yeung, R.Y.T., et al, Final Report for the Provision of Service
for Study of Short-Term Health Impact and Costs due to Road Traffic Air
Pollution. EPD Study Report, 2002a.
Wong, C.M.,
Atkinson, R.W., Anderson, R., Hedley,
A.J., and Ma, S., Chau, P.Y.K., Lam, T.H., A Tale of Two Cities: Effects of Air
Pollution on Hospital Admissions in Hong Kong and London Compared,
Environmental Health Perspectives, Volume 110, 2002b.
Wong, CM, Thach TQ,
Chau PYK, Chan EKP, Chung RYN, Ou C-Q, Yang L, Peiris JSM, Thomas GN, Lam TH, Wong TW, Hedley AJ. Public
Health and Air Pollution in Asia (PAPA): Coordinated studies of short-term
exposure to air pollution and daily mortality in four cities. Part 4:
Interaction between air pollution and respiratory viruses: Time series study of
daily mortality and hospital admissions in Hong Kong. Research Report No. 154,
Health Effects Institute, Boston, MA, U.S.A. November 2010.
Wong TW, Tam W, Yu ITS, Wun YT, Wong AHS, Wong
CM. Association between Air Pollution and General Practitioner Visits for
Respiratory Diseases in Hong Kong. Thorax 2006;
61:585-591.